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Abstract	
The development of the central nervous system relies on the tight regulation of the 
neural progenitor proliferation and differentiation in order to generate new neurons. 
The transcription factor Pax6 coordinates these functions during the development of 
the mammalian forebrain, using the paired DNA binding domain. This is a bipartite 
DNA-binding domain constituted by two subdomains, the PAI and the RED, binding the 
DNA in a cooperative or independent manner in order to control specific targets. 
Focusing on the activity of Pax6 as regulator of cell proliferation and of cell fate 
determination, I aimed to understanding how these functions are regulated at the 
molecular level, using the developing ventral forebrain as a model. 
In this work the role of the RED domain of Pax6 as a regulator of cell cycle progression 
is investigated. The mutation of the RED subdomain leads to an increase of progenitors 
in active mitosis (phospho-histone3 positive cells) in the ventral telencephalon at 
midneurogenesis. Similar result was obtained in the progenitors of the dorsal 
telencephalon. The increment in the phospho-histone3 positive cells is followed by the 
increase in cell death in both dorsal and ventral forebrain. These evidences suggest 
impairments in the cell cycle progression of the progenitor cells in the RED domain 
mutant. 
The importance of full activity of the RED domain of Pax6 for the proper progression of 
the cell cytokinesis is shown via ex-vivo live imaging, performed on ventral developing 
forebrain of Pax6
Leca2
 mutant animals (RED domain mutant). 
To elucidate the molecular mechanisms underlying the observed phenotype, 
transcriptome of the Pax6
Leca2
 mutants and their age matching siblings is analyzed, 
identifying a potential candidate gene: the Holliday junction recognition protein 
(HJURP). The overexpression of the HJURP protein in the wild type progenitors in vitro 
resembles the impairment of cytokinesis observed in Pax6
Leca2
 mutant. 
In summary, my data suggest new mechanisms for the regulation of cytokinesis in 
progenitors mediated by the RED domain of Pax6 and indicate that the full 
functionality of the paired domain is a prerequisite for Pax6 to function as fate 
determinant. 
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1 Introduction	
The mammalian brain comprises a variety of cell types. The two major populations are 
the neurons, specialized in conducting signals to other cells, and the glia cells 
comprising various cells important to preserve homeostasis and provide support and 
protection to the neurons. 
During brain development the neural stem cells represent the source of all the 
neurons in the mammalian brain as well as of the astrocytes and oligodendrocytes 
(Gotz and Huttner, 2005). The commitment of a cell to a specific fate can be 
determined by the environment surrounding the cells providing different cues (non-
cell autonomous) and by a gene expression program pre-specified in the cells (cell 
autonomous). The proper development of the brain requires a fine regulation of the 
combination of these extrinsic and intrinsic fate determinants in order to define the 
correct number of each cell type at the right time and place (Guillemot et al., 2006; 
Johansson et al., 2010; Lui et al., 2011; Tiberi et al., 2012). 
A cell intrinsic factor, that is regulating the commitment of the neural stem cells to the 
neuronal fate, is Pax6. In the developing cortex in fact the transcription factor Pax6 is 
expressed in neural stem cells and controls their proliferation as well as the time they 
exit the cell cycle in order to proceed to differentiation (Warren et al., 1999). Pax6 is 
important for the generation of superficial cortical neurons (Schuurmans et al., 2004; 
Georgala et al., 2011b). In addition Pax6 is also important for the generation of 
olfactory bulb interneurons originating from the ventral part of the telencephalon and 
are produced lifelong in the adult lateral wall of the subependymal zone (Merkle et al., 
2004; Hack et al., 2005; Merkle and Alvarez-Buylla, 2006). More insights on the 
functions of this transcription factor will be described further in the chapter. 
1.1 Early	brain	development	
After the neurulation process and prior to the onset of neurogenesis (embryonic days 
E7-9 in mice), the neural plate and the neural tube are composed by a single layer of 
neuroepithelial cells (NE). 
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The NE cells, characterized by apical- basal polarity, form a pseudostratified layer of 
cells. The appearance of the neuroepithelium in layers is given by the nuclei of the cells 
that are performing the so called interkinetic nuclear migration (INM). During this 
process the nucleus of every NE cell moves in the direction of the basal lamina (a thin 
layer of extracellular matrix at the pia surface) during G1 and S phase of the cells cycle 
and moves back to the apical side (at the ventricular surface) in G2 phase undergoing 
to mitosis directly at the apical side (Sauer, 1935; Takahashi et al., 1993). 
 
Figure 1: Vertebrate brain and spinal cord development 
Schemes taken from Sanes, Reh and Harris; Development of the Nervous System. 
(A) The primary structures appearing are the forebrain (prosencephalon), midbrain (mesencephalon), and hindbrain 
(rhombencephalon). These structures further differentiate and the forebrain generates the telencephalic vesicles 
and the diencephalon, while the rhombencephalon divides into the metencephalon and the myelencephalon (B). 
The basic brain divisions are then maintained in the adult one (C). 
 
The rostral region of the neural tube differentiates in three primary vesicles: forebrain 
(prosencephalon), midbrain (mesencephalon) and hindbrain (rhombencephalon) 
(Figure 1 A). These three regions further subdivide in five secondary brain vesicles. The 
forebrain gives rise to the anterior telencephalon and the more caudal diencephalon. 
The hindbrain further differentiates into an anterior metencephalon, forming the pons 
and the cerebellum, and a posterior myelencephalon giving rise to the medulla 
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oblongata (Figure 1 B) (Melton et al., 2004). The anterior-posterior regionalization 
finally ends in the caudal part of the neural tube where it specifies the spinal cord. 
 
 
Figure 2: Organization of the telencephalon 
Scheme taken from (Puelles et al., 2013) summarizing the subdivision of the telencephalon area of interest in this 
work. (A-B) Diagrams of a lateral view of developing mouse brain. The forebrain is subdivided in the telencephalon 
and diencephalon. The telencephalon subdivides into the pallium, in the dorsal side, and subpallial regions ventrally. 
 
The most anterior vesicle, the telencephalon, gives rise to the cerebral cortex or 
pallium dorsally whereas the ventral region generates the lateral and the medial 
ganglionic eminences (LGE and MGE) which will result in the striatum and the pallidum 
respectively (Figure 2). 
At the cellular level, while the neurogenic process proceeds, the NE cell populating the 
telencephalic area are transformed in the radial glia cells (RG).  
The RG cells similarly to the NE have apical- basal polarity and undergo INM. These 
cells differentiate from the NE because of the expression of some astroglial markers 
like vimentin, the glial glutamate/ aspartate transporter GLAST, the brain lipid binding 
protein (BLBP) which are all lacking in the NE (Gotz and Huttner, 2005; Sild and 
Ruthazer, 2011). 
In the dorsal telencephalon, the RG cells either directly differentiate to neurons or give 
rise to basal progenitors (BP), also known as intermediate progenitors, that are located 
in the subventricular zone (abventricular region)(Figure 3). These progenitors are 
distinguished from the RG cells by the expression of distinct transcription factors 
(Englund et al., 2005). Aside the expression of different factors, the BP cells 
differentiate morphologically from the RG. BPs are lacking the apical-basal polarity and 
do not undergo INM. In the dorsal telencephalon, these progenitors divide in basal 
Introduction 
4 
 
subventricular area and undergo symmetric cell division which leads to the increase of 
the numbers of neurons generated per round of division (reviewed in (Gotz and 
Huttner, 2005). 
 
Figure 3: Glial nature of embryonic and adult neural stem cells 
Scheme from (Kriegstein and Alvarez-Buylla, 2009) summarizing the different progenitors in the embryonic and 
adult brain and their mode of division. Neuroepithelial cells in early development divide symmetrically to amplify 
their pool. As the brain development proceeds neuroepithelial cells convert into radial glial (RG) cells. RG divide 
asymmetrically to generate neurons directly or indirectly through intermediate progenitor cells (nIPCs). A 
subpopulation of RG retain apical contact and continue functioning as adult NSCs in the neonate in specific regions 
where neurogenesis continues lifelong. Colors depict symmetric, asymmetric, or direct transformation. IPC, 
intermediate progenitor cell; MA, mantle; MZ, marginal zone; NE, neuroepithelium; nIPC, neurogenic progenitor 
cell; oIPC, oligodendrocytic progenitor cell; RG, radial glia; SVZ, subventricular zone; VZ, ventricular zone. 
1.2 Ventral	telencephalon	
Dorso-ventral patterning starts, in the telencephalon, early during development after 
the closure of the anterior neuropore with the appearance of three primitive ventral 
structures composing the subpallium. These structures are all protruding into the 
ventricular lumen in a specific temporal order: first the medial ganglionic eminence 
(MGE) at embryonic day 9 (E9), then the lateral ganglionic eminence (LGE) at E10 and 
finally the caudal ganglionic eminence (CGE) at E11 (Kohtz et al., 1998; Rallu et al., 
2002). 
The subpallial area gives rise to the multiple neuronal types that form the basal 
ganglia, parts of the amygdala and the septum. In particular the LGE is giving rise to 
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the caudate and the putamen and the MGE is forming amygdala and globus pallidus 
(Reiner et al., 1998). 
From the subpallial region is also originating a variety of cortical interneurons. 
Differently from the cerebral cortex where the projection neurons build up a cortical 
plate of 6 layers (Molyneaux et al., 2007), the striatum is organized in a mosaic pattern 
of patches and surrounding matrix (Gerfen, 1992). Patch neurons are born in two 
waves; the first wave is between E10.5-E11, the second wave of patch neurons is 
between E12.5-E13.5. Matrix neurons are born later (Fishell and van der Kooy, 1987; 
Mason et al., 2005; Liao et al., 2008). 
 
 
Figure 4: Dorsal and ventral telencephalon specification 
(A) Scheme taken from (Hebert and Fishell, 2008); (B) scheme taken from(Schuurmans and Guillemot, 2002). (A). 
The factors that act early to establish broad telencephalic regions are in blue. Sonic hedgehog (SHH) ventralizes the 
telencephalon antagonizing the effect of GLI3 (dorsalizing factor). FoxG1 and FGF signaling are necessary to form all 
regions of the telencephalon (shown in green), except for the dorsomedial region (shown in orange). Downstream 
transcription factors, such as GSH2 and NKx2.1, then form specific subdivisions. (B) The dorsal telencephalon 
specification directed by the expression of Pax6 and Ngn1/2 antagonizing with the ventralizing factors Gsh1/2 and 
Ascl1/ Mash1. 
 
The development and the specification of the ventral telencephalon identity are 
governed by a variety of morphogens and transcription factors like Gsx1/2, Ascl1 and 
Dlx1/2 (Schuurmans and Guillemot, 2002; Hebert and Fishell, 2008) (Figure4). 
1.2.1 Lateral	Ganglionic	Eminence	specification	and	neurogenesis	
The LGE is anatomically defined as the bulge that is protruding into the ventricle in the 
area located between the cortex and the MGE. From the molecular point of view, the 
LGE is characterized by the expression of Dlx1/2/5 (Bulfone et al., 1993) as well as the 
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expression of Isl1, Gsx2, ER81 and Pax6 (Stoykova et al., 1996; Szucsik et al., 1997; 
Sussel et al., 1999; Stenman et al., 2003; Flames et al., 2007). The dorsal border of the 
LGE with the cortex is defined as ventral pallium (Puelles et al., 2000). In the ventral 
pallium Tbr2, Ngn2, and Dbx1 are expressed whereas Dlx2 is absent (Puelles et al., 
2000; Yun et al., 2001). The border between the LGE and the MGE is identified by a 
high expression of Nkx2.1 (Puelles et al., 2000; Garcia-Lopez et al., 2008) (Figure 4). 
The progenitors in the LGE are distinct in four domains, all extending (except the 
ventral pLGE4) along the rostro-caudal extent of the subpallium (Flames et al., 2007). 
Two domains of the dorsal LGE are discriminated by the differential expression of Pax6 
and ER81 (Stenman et al., 2003; Carney et al., 2006; Waclaw et al., 2006; Flames et al., 
2007). The dorsal LGE is thought to give rise to interneurons migrating to the olfactory 
bulb (Toresson et al., 2000; Yun et al., 2001; Stenman et al., 2003; Waclaw et al., 2006) 
and to contribute to distinct populations of postmitotic neurons forming the striatum 
proper and the central amygdala (Moreno et al., 2009).  
The ventral LGE is the most prominent part of the LGE and is divided in two further 
domains. These two domains express Nkx6.2 (Flames et al., 2007) and give rise to Isl1 
expressing cells in the SVZ (Stenman et al., 2003). 
 
Figure 5: Production and migration of different neurons in the ventral telencephalon 
Scheme representing the telencephalic hemispheres from E14 mouse embryos (Wilson and Rubenstein, 2000). (A) 
Expression patterns in the progenitor zones of the transcription factors implicated in the regulation of telencephalic 
patterning and differentiation. (B) Subdivisions of the telencephalic proliferative zone and location of precursor cells 
producing neurons expressing the neurotransmitters, glutamate, GABA, and acetylcholine. (C) Migration pathways 
from different progenitors zones. 
 
The progression of neurogenesis in the ventral telencephalon is under the control of 
the proneuronal factor Ascl1 (Mash1) (Casarosa et al., 1999). In this context Ascl1 is 
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not only acting as neural determinant but it is also conferring ventral neuronal identity 
due to the regulation of Dlx and GAD67, the enzyme synthetizing GABA (Casarosa et 
al., 1999; Fode et al., 2000; Parras et al., 2002; Poitras et al., 2007; Castro et al., 2011). 
Ascl1 is also responsible for the generation of an early population of subpallial 
oligodendrocytes cooperating with the transcription factor Olig2 (Parras et al., 2007). 
Differently from the pallium, where the projection neurons (glutamatergic neurons) 
reach their final position via radial migration from their ventricular progenitor zone, in 
the subpallial region the majority of telencephalic interneurons migrate following 
tangential routes to integrate into their final destination (Marin and Rubenstein, 2001; 
Marin and Rubenstein, 2003) (Figure 5). The streams of migration of the interneurons 
are classified according to the timing of migration, the subpallial domain of origin and 
the target region (Corbin et al., 2001; Nadarajah and Parnavelas, 2002; Flames and 
Marin, 2005; Metin et al., 2006). Hence, cortical GABA interneurons arise through two 
main tangential migrations, a superficial pathway, which originates in the MGE 
(Anderson et al., 1999; Lavdas et al., 1999; Sussel et al., 1999; Wichterle et al., 1999; 
Pleasure et al., 2000; Anderson et al., 2001) and a deep pathway originating from the 
LGE (de Carlos et al., 1996; Tamamaki et al., 1997; Pleasure et al., 2000; Anderson et 
al., 2001) (Figure 5). 
1.2.1.1 Progenitor	cells	diversity	in	the	LGE	
Differently from the cortex where the vast majority of progenitor cells are within the 
ventricular zone (VZ), in the LGE the most prominent number of proliferating 
progenitors is located abventricularly (Pilz et al., 2013). 
The apical progenitors (AP) are the cells undergoing mitosis at the luminal surface of 
the VZ. The AP cell population in the ganglionic eminence, is composed by two cells 
types that undergo interkinetic nuclear migration: the bipolar radial glia cells (RG) and 
the short neural precursors (SNP) (Pilz et al., 2013). The SNPs are unipolar with a 
unique apical process. The apically dividing RG cells asymmetrically divide and, besides 
self-renewing, they produce either SNPs or a subapically dividing progenitors (SP) (Pilz 
et al., 2013) (Figure 6). The SNPs undergo further steps of amplification. The SNPs 
amplification represents a peculiar characteristic of the ventral telencephalon (Pilz et 
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al., 2013); in the cerebral cortex, in fact, the SNPs directly generate postmitotic 
neurons (Gal et al., 2006; Stancik et al., 2010; Tyler and Haydar, 2013). 
Both RGs and SNPs are giving rise to SP (Figure 6). This population of cells has been 
recently identified in the LGE (Pilz et al., 2013). The SP progenitors undergo mitosis in a 
region comprised within 10 rows of cells from the apical surface. Beside the common 
proliferative zone, the SP cells are very heterogeneous in terms of morphology. 
 
 
Figure 6: Progenitor cells in the cortex vs LGE 
Scheme illustrating the progenitors present in the LGE and in the cortex.(Pilz et al., 2013). RG are in white, short 
neural precursors (SNP) are in light red; they both divide apically but the SNPs present only one process at the apical 
side. In light blue the SP dividing within 10cells rows from the ventricle. BPs are depicted in green and divide in the 
SVZ. In the cortex RG cells divide at the ventricle and give rise to neurons in yellow directly or to BP in green dividing 
in the SVZ. Abbreviations: AS (apical side); VZ (ventricular zone); SVZ (subventricular zone). 
 
In the LGE SPs are positive for radial glia markers like RC2 and GLAST and also express 
Sox2, Ascl1, Dlx2 and Pax6 (Pilz et al., 2013). The SPs amplify the pool of proliferating 
progenitors in the LGE and they also give rise to basal progenitors (BP) (Pilz et al., 
2013). 
In term of cell cycle progression, live imaging experiments in the LGE area revealed 
that the RGs are the cells with the longest cell cycle (25h in average). The cell cycle 
length of SNPs and SPs is about 17h and the second generation of SPs from SNPs or SPs 
themselves is significantly shorter (12h) (Pilz et al., 2013). These observations suggest 
that besides a series of division that fasten the cell cycle of the progeny, these fast 
divisions are necessary to amplify the number of progeny in a given time; those are all 
hallmarks of the adult neural stem cells lineages emerging from this region (Pilz et al., 
2013). 
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1.3 Adult	brain	from	the	LGE	
In mammals, radial glial cells populating the brain during development disappear after 
birth even if some RG-like cells persist in few areas during adulthood (Figure 7). The 
adult NSCs (aNSC) and the radial glia cells belong to the same lineage (Merkle et al., 
2004). In particular, radial glial cells of the neonatal lateral ventricular wall (Figure 7 C) 
occupy the same region as the astrocytic stem cells of the adult subedendymal zone 
(SEZ) (Figure 7 D). This led to the conclusion that the primary progenitors for the 
postnatal generation of new neurons in the adult SEZ zone are regionally specified and 
the organization of the aNSCs in different domains is defined before birth (Figure 7) 
(reviewed in(Merkle and Alvarez-Buylla, 2006)). 
The adult SEZ is the largest germinal zone in the adult mammalian brain and is located 
at the lateral wall of the lateral ventricle. In this region are generated the new neurons 
that migrate through the OB via the rostral migratory stream (RMS) (Luskin, 1993; Lois 
and Alvarez-Buylla, 1994) and glial cells destined to the corpus callosum (CC) (Hack et 
al., 2005; Menn et al., 2006). 
The SEZ niche consists of slow proliferating cells, the stem cells (also called Type B 
cells), that, via multistep process of fate restriction, switch from multipotent cells 
towards more fate-restricted precursors the transit amplifying progenitors (type C) and 
neuroblasts (type A), which further differentiate resulting in new neurons that 
functionally integrate into the OB system. 
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Figure 7: Neural stem cells and their progeny in adult brain 
Schematic drawing from (Merkle and Alvarez-Buylla, 2006).  
The NSCs of the lateral ventricule, in blue, change their shape and produce different progeny as the brain develops. 
They begin as neuroepithelial cells and transform into radial glial cells having NSCs characteristics. RGs contact with 
the ventricle, into which they project a primary cilium and produce progeny either directly or via an intermediate 
progenitors, in green. (A) At early developmental stages the CNS is a tubular structure, composed of neuroepithelial 
cells, which divide symmetrically to expand the stem cell pool. (B) Neuroepithelial cells differentiate into embryonic 
radial glial cells, which divide to generate striatal neurons and oligodendrocytes, either directly or via an 
intermediate progenitor. The radial processes of radial glial cells support the migration of neuroblasts, in red. (C) 
Radial glial cells persist in the neonatal brain, where they generate oligodendrocytes, olfactory bulb interneurons, 
and ependymal cells. They also generate astrocytes, some of which remain stem cells in the adult. (D) In the adult 
brain, adult NSCs retain a radial process and contact both the ventricle and the basal lamina of blood vessels. They 
generate oligodendrocytes and olfactory bulb interneurons. Abbreviations: Stri, striatum; SVZ, subventricular zone; 
VZ, ventricular zone. 
1.3.1 Transit	amplifying	progenitors	
The transit-amplifying progenitors (TAPs or Type C) represent a class of fast cycling 
cells within the SVZ. They originate directly from the slow dividing aNSCs. 
Clonal analysis highlighted that TAPs undergo 3-4 rounds of symmetric proliferative 
divisions (Ponti et al., 2013; Calzolari et al., 2015) and seem to divide in close proximity 
to blood vessels (Tavazoie et al., 2008). 
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At the molecular level, this cell type can be isolated from the other populations by the 
expression the EGF receptor (Morshead et al., 1994; Doetsch et al., 2002). 
At least two different lineages of the fast proliferating intermediate progenitors have 
been identified within the SVZ: TAPs that generate oligodendrocytes migrating towards 
the white matter (Hack et al., 2005; Marshall et al., 2005; Menn et al., 2006; Colak et 
al., 2008) and TAPs that give rise to immature neuroblasts migrating via the rostral 
migratory stream (RMS) into the OB (Doetsch et al., 2002; Parras et al., 2004; Hack et 
al., 2005; Menn et al., 2006; Colak et al., 2008). This difference in TAPs fate is 
generated at the level of the aNSCs where they either generate neuronal or 
oligodendroglial lineage (Ortega et al., 2013). 
1.3.2 Neuroblasts	
Neuroblasts or Type A cells originate from the TAPs. These cells are characterized by 
their capability to tangentially migrate to the OB. Once the neuroblasts reach the OB, 
they radially migrate to reach their final location. 
These young neurons are characterized by the expression of factors like polysialic acid 
(PSA-NCAM), doublecortine (Dcx), and CD24. They show properties of already 
differentiated neurons but continue to divide in the SVZ and on their way to the OB. 
For this reason, they appear to be BrdU positive upon short pulses of this compound 
similarly to the TAPs (Luskin, 1993). 
The main feature of these cells is that they migrate covering long distances from the 
lateral wall of the ventricle to reach the OB. The migration along the rostral migratory 
stream is mediated by molecules like chemoattractants and chomorepellents, as well 
as proteins of extracellular matrix and proteins present on the cell surface (Hagg, 
2005). In addition their migration is regulated by the blood vessels delimiting the route 
of migration (Snapyan et al., 2009) and the astrocytic tube that avoids the dispersion 
of cells in the surrounding tissue (Ghashghaei et al., 2007). 
In the SEZ-RMS system, both neuroblasts and some TAPs are characterized by the 
expression of the transcription factor Pax6 (Hack et al., 2005; Brill et al., 2008) and this 
feature will be relevant in the following chapters. 
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1.4 The	transcription	factor	Pax6	
Pax6 is a member of the Pax family of transcriptional regulators. This gene is located 
on the chromosome 2 in mice (chromosome 11 in humans) and encodes for a highly 
conserved protein of 422 amino acids. 
Pax6 protein is involved in the development of the eyes, brain, spinal cord, and 
pancreas. Pax6 is additionally expressed in the pituitary, the gut and the olfactory 
epithelium (Walther and Gruss, 1991; Callaerts et al., 1997). 
In mice, losing the functionality of this protein leads to the death of the animal shortly 
after birth (Hogan et al., 1986). 
In the developing CNS Pax6 is widely expressed including the forebrain, hindbrain, 
cerebellum and spinal cord (Walther and Gruss, 1991; Grindley et al., 1995). 
 
 
Figure 8: Pax6 expression in embryonic and adult brain 
(A-C) Pax6 in situ hybridization from the GenePaint.org the digital atlas of gene expression patterns in the mouse. 
(A) Pax6 expression at E10, (B) at E14 and (C) at postnatal stages. 
 
In mice (Figure 8) Pax6 starts to be expressed as early as embryonic day 8.5 (E8.5) 
when the neural tube is closing. In the dorsal telencephalon the peak of expression is 
reached at E14 (peak of neurogenesis) and declines as gliogenesis starts (E18) (Gotz et 
al., 1998; Englund et al., 2005). 
In the adult CNS, Pax6 is detected in the neurons of various regions including the 
cerebellum, the thalamus, the olfactory bulb and the amygdala (Stoykova and Gruss, 
1994; Engelkamp et al., 1999; Kawano et al., 1999; Yamasaki et al., 2001; Tole et al., 
2005). 
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Figure 9: Pax6 expression in the SEZ and SGZ population 
(A-B) Schemes taken from (Hsieh, 2012). The scheme is depicting the SEZ (A) and SGZ (B) niches respectively and 
highlights the expression of Pax6 in certain cells population along the lineage. 
 
Pax6 is expressed in the two most known neurogenic regions of the postnatal brain: 
the subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) and the 
subependymal zone (SEZ) in the ventricular zone (Hsieh, 2012)(Figure 9). 
In the SGZ, the transcription factor is expressed in a subpopulation of neural stem cells, 
in early progenitor cells presenting a radial glia like morphology and in a small 
population of late progenitors (Maekawa et al., 2005; Nacher et al., 2005) (Figure 9). 
In the SEZ, Pax6 is expressed in a subpopulation of TAPs and immature neurons that 
migrate via the rostral migratory stream (RMS) to the olfactory bulbs (OB) (Figure 9). In 
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the OB Pax6 is relevant for the survival of the dopaminergic neurons (Hack et al., 2005; 
Kohwi et al., 2005; Ninkovic et al., 2010). 
1.4.1 Pax6	in	development	
Most of the knowledge concerning the functions of Pax6 derives from the analysis of 
the phenotype of mutants animals where the Pax6 function is lost. One of these is the 
small eye mutant (Pax6
Sey
) which is carrying a non-functional Pax6 protein. 
The Pax6
Sey
 is characterized by a natural occurring point mutation that generates a 
truncated protein lacking the transactivation domain at the C-terminus and 
considered, for this reason, non-functional (Hill et al., 1991). 
From the analysis of these mutants was possible to define the necessity of the Pax6 
protein for the eye and brain development. In the heterozygotes mice the eye is 
smaller, as suggested by the name, but is completely missing when the mutation is in 
both alleles of the gene (Hogan et al., 1986; Osumi et al., 2008). Pax6 is also essential 
for the development of the lens and the retina, (Ashery-Padan et al., 2000; Ashery-
Padan and Gruss, 2001; Kozmik, 2005; Graw, 2010; Shaham et al., 2012; Cvekl and 
Ashery-Padan, 2014). 
In the brain, losing Pax6 functionality leads to a reduction of the brain size due to a 
smaller cerebral cortex composed by a thinner cortical plate (Schmahl et al., 1993; 
Heins et al., 2002; Asami et al., 2011). In the developing telencephalon the 
transcription factor regulates essential processes like the proliferation of the cells, the 
neurogenic fate determination and the regionalization of the telencephalon defining 
the borders between the dorsal and the ventral area (Haubst et al., 2004; Georgala et 
al., 2011a). 
1.4.1.1 Patterning	
The establishment of the dorso ventral border delimited by the so called pallial-
subpallial boundary (PSB), a physical boundary composes by RG cells highly expressing 
Pax6, is under the control of the transcription factor Pax6. When this protein is non-
functional (e.g.Pax6
Sey
), the PSB is severely disrupted (Stoykova et al., 1997) leading to 
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an increase of the cell migrating from the ventral telencephalon to the cerebral cortex 
(Chapouton et al., 1999). In addition, the expression of dorsal factors like Ngn2 and 
Tbr2 is lost (Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001; Haubst et al., 
2004) and ventral factors like Gsx1/2, Ascl1, Dlx1/2 and Olig2 take over spreading in 
the dorsal area (Stoykova and Gruss, 1994; Stoykova et al., 1996; Stoykova et al., 1997; 
Toresson et al., 2000; Yun et al., 2001; Heins et al., 2002). 
It is not only the specification of dorsal versus ventral regions in the telencephalon that 
depends on Pax6, but also arealisation of the cerebral cortex (Bishop et al., 2000; 
Bishop et al., 2002; Muzio et al., 2002a; Muzio and Mallamaci, 2003). 
Pax6 is expressed in a gradient with high expression rostro-lateral and low expression 
caudal-medial, in an opposing manner if compared with the expression of Emx1 and 
Emx2 (other two dorsally expressed transcription factors). Losing the functionality of 
Pax6 leads to the expansion of Emx2 and in turn to the anterior expansion of the 
primary visual area. The loss of a functional Emx2 leads to the caudal expansion of 
Pax6 and the consequent expansion of domains containing somatosensory and motor 
neurons (Bishop et al., 2002; Muzio et al., 2002a; Muzio et al., 2002b; Muzio and 
Mallamaci, 2003). 
Changes in regionalization due to loss of functional Pax6 have also been observed in 
other regions of the CNS, as in the ventral diencephalon, hindbrain and spinal cord 
(Briscoe et al., 1999) (Stoykova et al., 1996; Grindley et al., 1997; Osumi, 2001). 
1.4.1.2 Fate	determinant	
Pax6 is involved in the regulation of the neurogenic process.  
In the dorsal telencephalon of Pax6 deficient mice, neurogenesis is strongly impaired 
(Schmahl et al., 1993; Heins et al., 2002), whereas the ventral telencephalon is not 
affected. This impairment is due to the fact that at the peak of neurogenesis the RG 
cells express the Pax6 protein (Gotz et al., 1998; Hartfuss et al., 2001). The loss of Pax6 
functionality in the Pax6
Sey
 mice leads to a decrease in the RG cells neurogenic 
potential (Heins et al., 2002; Haubst et al., 2004) whereas the basal progenitors in the 
SVZ are not affected (Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). 
Conversely Pax6 overexpression enhances in vitro neural production from RG (Heins et 
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al., 2002; Haubst et al., 2004). This neurogenic potential is not restricted in time and 
region since the overexpression of Pax6 results in a fate conversion of already 
committed glia cells in postnatal (Heins et al., 2002) and fully adult brain derived cells 
(Hack et al., 2004). 
1.4.1.3 Proliferation	
The neurogenic function of Pax6 and the capability of regulating the cell cycle are very 
much linked. The fact that it drives cells to the neuronal fate means that, when 
overexpressed, Pax6 forces cells to exit the cell cycle and start differentiating. 
In the developing cortex, the deletion of Pax6 leads to an increase of proliferation in 
the progenitors located in non-apical positions (Gotz et al., 1998; Estivill-Torrus et al., 
2002; Haubst et al., 2004; Quinn et al., 2007; Tuoc et al., 2009). This increase in 
proliferation was explained also by the loss of the dorsal area specification, as 
described before. In addition, when Pax6 is not functional, progenitors located apically 
delaminate prematurely and contribute to the non-apical increase of proliferating 
progenitors (Asami et al., 2011). 
Differently from the developing cortex, where loss of Pax6 contribute to increase of 
proliferation, in other regions like the diencephalon, the eye and in different type of 
cells like the postnatal glia progenitors, when Pax6 is lost proliferation decreases 
(Warren and Price, 1997; Marquardt et al., 2001; Sakurai and Osumi, 2008). In the 
cerebellum of Pax6
Sey
 animals, the proliferation of progenitors is not affected 
(Engelkamp et al., 1999). 
These various responses upon lacking of Pax6 functionality underline the fact that the 
capability of Pax6 to regulate proliferation of cells is not only cell type specific but also 
region related. 
1.4.2 Pax6	protein	structure	
The Pax6 protein contains different DNA binding domains: the paired domain (PD) at 
the amino terminal, shared by all the members of the Pax family (Chalepakis et al., 
1992); a homeodomain (HD) and a transactivation domain (TA) at the carboxy terminal 
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(Glaser et al., 1992). The PD is further differentiated in two DNA binding subdomains: 
the N-terminal subdomain or PAI and the C-terminal subdomain or RED (Walther et al., 
1991; Czerny et al., 1993; Epstein et al., 1994b; Epstein et al., 1994a; Jun and Desplan, 
1996; Xu et al., 1999). The sequence that is recognized by the PAI is named P6CON 
whereas the one recognized by the RED is the 5aCON (Epstein et al., 1994b; Chauhan 
et al., 2004; Xie et al., 2013; Xie et al., 2014). 
 
Figure 10: Pax family and Pax6 domains 
Graph depicting all the members of the Pax family from (Mahajan et al., 2014) and the structure of the PD and HD 
of the human Pax6 gene from crystallographic analysis (Callaerts et al., 1997). 
 
Crystallographic analyses of the human PD DNA complex of Pax6 revealed that the PAI 
domain contains two extended β-sheets and three α-helices between 20 to 60 amino 
acids residues. The RED subdomain is constituted by three α helical regions (Figure 10). 
The HD is predicted to have three α-helices where the third of them is contacting the 
major groove of the DNA and is necessary for sequence recognition (Bruun et al., 
2005). Differently from other sequence specific DNA binding proteins that use only one 
DNA binding domain, Pax6 can use all its DNA binding parts or a range of their 
combinations to bind to the DNA (Xie and Cvekl, 2011). 
The Pax6 gene generates different transcripts variants either by alternative splicing or 
by the usage of an alternative promoter. One of the most commonly expressed Pax6 
variants is the Pax6(5a). This splice variant has an insertion of 14 amino acids in the PAI 
subdomain (Walther and Gruss, 1991; Glaser et al., 1992; Puschel et al., 1992) leading 
to abolishment of the binding activity of the subdomain with the retention of the RED 
domain functionality (Epstein et al., 1994b; Kozmik et al., 1997; Anderson et al., 2002). 
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The canonical form of Pax6 together with the splice variant Pax6(5a) are expressed in 
the developing brain, eye, spinal cord and in the olfactory epithelium (Walther and 
Gruss, 1991; Glaser et al., 1992) even if the Pax6(5a) is expressed at lower levels. 
The second major isoforms is missing the PD domain and its activity is restricted to the 
functional HD and TA. The PD-less form (Mishra et al., 2002) is present in the adult 
brain, pancreas and eye (Walther et al., 1991; Turque et al., 1994; Grindley et al., 1995; 
St-Onge et al., 1997) and is found also in the invertebrates differently from the 
Pax6(5a) which is specific for vertebrates (Miles et al., 1998). 
As mentioned in the previous sections, Pax6 is involved in the regulation of many 
developmental processes, such as the regulation of cell proliferation, neurogenesis and 
brain patterning. Recently many genes regulating these functions have been identified 
(Sansom et al., 2009; Wolf et al., 2009; Coutinho et al., 2011; Xie and Cvekl, 2011) and 
it was also shown how Pax6 positively regulates them (Sansom et al., 2009). However, 
in order to understand how Pax6 coordinates the regulation of these multiple 
functions at the molecular level, the role of the different DNA-binding domains has 
been analyzed in loss- and gain- of function approaches in different regions of the 
brain (Haubst et al., 2004). 
From this analysis was evident that the homeodomain (HD) of Pax6 is not relevant for 
any of the above mentioned functions of Pax6 during brain development. In the 
mutant line Pax6
4NEU
, where the DNA-binding properties of the HD are disrupted by a 
point mutation leading to an amino acid substitution, no defect was evident in the 
brain region specification, in cell proliferation or differentiation (Haubst et al., 2004). 
Moreover no defect was detectable also at later stages (Ninkovic et al., 2010). These 
observations imply that most of the roles exert by Pax6 during development might be 
mediated by the bipartite PD domain. 
1.4.2.1 Pax6	PD	mutants:	Pax6Leca2	and	Pax6Leca4	
In order to discriminate the role of the two subdomain of the PD in regulating 
neurogenesis, brain patterning and cells cycle regulation, two mouse line Pax6
Leca2 
and 
Pax6
Leca4
 were analyzed during their brain development (Walcher et al., 2013). 
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Each of these two mutants is carrying a single point mutation in one of the two 
subdomains (Thaung et al., 2002) resulting in a substitution of lysine for asparagine 
(N50K) in the PAI domain (Pax6
Leca4
) or of cysteine for arginine (R128C) in the RED 
domain (Pax6
Leca2
). The RED domain mutation has been observed also in patients 
(Azuma et al., 1996). 
Both these mutations are predicted to affect the binding capacity of the domains to 
their consensus site and the milder eye phenotype, compared with the Pax6
Sey 
(full KO 
for Pax6), would be consistent with a selective disruption of only one of the subdomain 
at the time (Thaung et al., 2002). 
According to the eye phenotype, the craniofacial defects, and the reduction of the OB 
sizes both the homozygote mice for the two mutants line show similarities with the 
Pax6
Sey
 (Hill et al., 1991; Tzoulaki et al., 2005). However, the Pax6
Leca2
, in contrast with 
Pax6
Sey
 and the PAI domain mutants (Pax6
Leca4
), survive to adulthood.  
The Pax6
Leca4
 mutants are more similar to the Pax6
Sey
 than the Pax6
Leca2
. While the 
Pax6
Leca4 
have reduction in brain size due to a reduction in the cortical thickness and 
the misspecification of the dorso-ventral borders, the RED domain mutants do not 
presents these aberrations. In the Pax6
Leca2
 the cortical size is comparable with the 
wildtype (WT) control and as well the borders between dorsal and ventral area are 
maintained. Those are all considered insights that neither the neurogenic capacity of 
Pax6 nor its regulation of the brain regionalization is under the control of the RED 
domain (Walcher et al., 2013) (Figure 11). 
In terms of cell proliferation both the domains (PAI and RED) are important to regulate 
this function of Pax6 but in an opposite manner. In the Pax6
Leca2
 the cells in active 
mitosis, both the apical and basal progenitors, are almost doubled in their number 
when compared to the WT. Conversely when the same analysis is carried in the 
Pax6
Leca4
, both progenitors were significantly decreased. Apical and basal progenitors 
in both the mutants were still Pax6 and Tbr2/Eomes positive as expected and the RG 
cells were normal in their morphology. Hence only the number of cells in mitosis but 
not their identity is affected by the mutation of the PAI and the RED domains (Walcher 
et al., 2013). Notably this is in contrast with the Pax6
Sey
 where the apical progenitors 
proliferation is unaffected and the increase in non-apical proliferating cells is resulting 
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from the migration of cells from the ventral area (Gotz et al., 1998; Haubst et al., 2004; 
Tuoc et al., 2009) (Figure 11). 
The analysis of the RED and PAI mutants showed that Pax6 can exert opposing 
functions on the same cortical progenitor population, having the intact RED domain 
the capability of inhibiting proliferation and the PAI domain the capability of 
promoting proliferation. 
Interesting goals would be unraveling the molecular network controlled by the RED 
domain involved in the cell cycle control and, since this mutants survive to postnatal 
stages, investigate the repercussion of this mutation also on the adult neurogenesis. 
These achievements are partially reached with this work. 
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Figure 11: PD domain mutants Pax6
Leca2
 and Pax6
Leca4 
(A-D) Summary of the phenotype observed in the developing cortex of Pax6
Leca2
 and Pax6
Leca4 
mice in comparison to 
the WT and the Pax6
Sey
 in terms of regulations of progenitors proliferation, patterning and neurogenic functions of 
Pax6. (A) WT, (B) Pax6
Leca2
 that have no defects in patterning and neurogenic potential but have an increase in the 
mitotically active cells in SVZ and VZ. Opposite situation in Pax6
Leca4
 (C) where mitotic figures are decreased, there 
are patterning defects and the brain size is reduced with a thinner cortical plate. (D) Pax6
Sey
. Abbreviations: AP, 
apical progenitors; BP basal progenitors; PD, paired domain, HD, homeodomain; TA, transactivation domain. 
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2 Materials	and	Methods	
2.1 Materials	
2.1.1 Chemicals	
Chemical  Company 
4',6-diamidino-2-phenylindole 
(DAPI) 
AppliChem 
5’-bromo-2’-deoxyuridine (BrdU) Sigma-Aldrich 
Acrylamide 30% Roth 
Agarose Biozym 
Ampicillin Roth 
Aqua ad iniectabilia Braun 
Bovine Serum Albumin (BSA) Sigma-Aldrich 
Difco LB-Agar Hartenstein Laborversand 
DNA Ladder (Generuler 1kb) Fermentas 
D-Saccarose Roth 
EDTA  Merck 
Ethanol  Merck 
Glycerol Sigma-Aldrich 
Glycine AppliChem 
HEPES Roth 
Hydrochloric acid  Merck 
Isopropanol Merck 
Kanamycin sulfate Roth 
Low melting Agarose Biozym 
Mercaptoethanol  Merck 
Methanol Merck 
Milk powder Roth 
Normal goat serum (NGS)  Vector Laboratories 
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N-P40 (Nonidet-P40) ICN Biomedicals 
Paraformaldehyde (PFA) Merck 
PCR dNTP Mix (25mM each) Fermentas 
Protein ladder Page ruler plus Thermo Scientific 
Proteinase K Roth 
Sodium dodecyl sulphate (SDS) Roth 
Sodium phosphate (Na2HPO4•7H2O) Merck 
SYBR green Qiagen 
SYBR Safe Life Technologies 
TEMED Sigma-Aldrich 
Tissue Tek Hartenstein Laborversand 
Tris Base Sigma-Aldrich 
Tris-HCl Roth 
Triton-X100 Roth 
Tween-20 Sigma-Aldrich 
 
2.1.2 Kits	
Kit Company 
BigDye Terminator v3.1 Cycle Sequencing Kit 
Applied 
Biosystems 
DC Biorad protein Assay Kit Biorad 
Dye Ex 2.0 Spin Kit Qiagen 
ECL Western Blotting Detection 
Reagents(Amersham) 
GE Healthcare 
EndoFree Plasmid Maxi Kit Qiagen 
Maxima First Strand cDNA Synthesis Kit Thermo Scientific 
QIAquick Gel Extraction Kit  Qiagen 
QIAquick PCR Purification Kit Qiagen 
RNase Free DNase set Qiagen 
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RNeasy Mini Kit Qiagen 
Taq DNA Polymerase Qiagen 
 
2.1.3 Tissue	culture	reagents	
A summary of the media and reagents, needed to cultivate cells used in this work, 
follows in this section. 
Reagent Company 
B-27 Serum-Free Supplement Gibco (Life technologies) 
BD Matrigel Matrix Growth Factor Reduced  BD Biosciences 
Bovine serum albumin (BSA) Sigma-Aldrich 
D-Glucose (Stock 45%) Sigma-Aldrich 
DMEM (Dulbecco's Modified Eagel 
Medium)+4.5g/ml glucose and GlutaMAX 
Gibco (Life technologies) 
DMEM:F12 (Dulbecco's Modified Eagel 
Medium:Nutrient Mixture F12)+ GlutaMAX 
Gibco (Life technologies) 
DMSO Sigma-Aldrich 
EGF (Epidermal Growth Factor) Roche 
FCS (Fetal Calf Serum) Pan Biotech 
FGF2 (Fibroblast Growth Factor-2) Roche 
HBSS 1X (Hank's balanced salt solution) Gibco (Life technologies) 
HEPES (1M) Gibco (Life technologies) 
Horse serum (HS) Pan Biotech 
Hyaluronidase Sigma-Aldrich 
Laminin Roche 
L-Glutamine (200mM) Gibco (Life technologies) 
Lipofectamine 2000 Life technologies 
MEM Non-Essential Amino Acids Solution 
(100X) 
Gibco (Life technologies) 
N2 supplement Gibco (Life technologies) 
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Neurobasal Gibco (Life technologies) 
Opti-MEM +GlutaMAX Gibco (Life technologies) 
Penicillin/Streptomycin (Pen/Strep) Gibco (Life technologies) 
Poly-D-Lysine (PDL) Sigma-Aldrich 
Poly-L-ornithine Sigma-Aldrich 
Trypan Blue Gibco (Life technologies) 
Trypsin Sigma-Aldrich 
Trypsin (EDTA), 0.05% Gibco (Life technologies) 
 
2.1.4 Standard	solution	and	media	
2.1.4.1 Phosphate	Buffer	Saline	(PBS)	(0.15M)	
1.4M NaCl  
27mM KCl 
83mM Na2HPO4  
15mM KH2PO4  
5L of 10X stock solution of PBS are prepared by dissolving 400g NaCl; 10g KCl; 10g 
KH2PO4 and 73.66g Na2HPO4 x 2 H2O in ultrapure water followed by adjustments of the 
pH to 6.8. After autoclaving, the stock solution is diluted 1:10 with autoclaved water to 
have 0.15M 1X PBS with a pH 7.4. 
2.1.4.2 Paraformaldehyde	(PFA)	4%	
4% diluted PFA is prepared dissolving 40g of Paraformaldehyde in 800ml ultrapure 
water by gentle heating during stirring with the addition of 3NaOH pellets to enable 
the PFA powder to dissolve. The solution is cooled down to room temperature and the 
volume adjusted to 1L with 1X PBS The pH is then adjusted to 7.2 -7.3. The solution is 
then filtered through a paper filter and stored at 4°C. 
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2.1.4.3 50X	Tris	Acetate	EDTA	(TAE)	Buffer	
2M Tris acetate  
50mM EDTA  
To prepare 1L of 50X TAE-buffer 242g Tris Base; 57.1ml Acetic Acid and 100ml 0.5M 
EDTA are dissolved in 800ml autoclaved H2O. The pH is then adjusted to 8.0 with HCl 
and the solution filled up to 1L with autoclaved H2O. 
2.1.4.4 Lysis	Buffer	for	tail	DNA	extraction	
100mM Tris, pH 8.0-8.5 
200mM NaCl 
5mM EDTA, pH8.0 
2% SDS 
1L of Lysis buffer is prepared by mixing 100ml 1M Tris HCl; 10ml 0.5M EDTA; 20ml 10% 
SDS; 200ml 1M NaCl and 660ml autoclaved H2O. To proceed to the lysis, 10μl/ml of 
Proteinase K (10mg/ml) is added freshly to the Lysis solution. 
2.1.4.5 LB	medium	(Luria-Bertani)	
0.5% (w/v) NaCl 
1% (w/v) Bacto-Tryptone 
0.5% (w/v) yeast extract  
20mM Tris/HCl pH 7.5 
The pH value was adjusted to 7.0 with NaOH. 
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2.1.5 Solutions	and	media	
2.1.5.1 Ex	vivo	live	imaging	
2.1.5.1.1 Dissection Medium 
7.8g DMEM/F12 powder 
0.6g NaOH 
1.45g Glucose 
5ml Penicillin/Streptomycin 
495ml qH2O 
2.1.5.1.2 Reconstitution Medium 
10ml HEPES 1M 
1.25ml 2M NaOH 
1.09g NaHCO3 
40ml qH2O 
2.1.5.1.3 Collagen Matrix 
320μl cellmatrix Type I-A (Nitta Gelatin) 
120μl 5xDMEM 
60μl Reconstitution medium 
2.1.5.1.4 Slice culture Medium 
17.4ml Dissection Medium 
1ml HS 
1ml FCS 
400μl B27 
200μl N2 
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2.1.5.2 Ex	vivo	SEZ	explant	
2.1.5.2.1  Explants culture Medium 
Neurobasal (Gibco-Life Technology)  
1ml B27 supplement 
400µl HEPES 
500µl P/S 
500µl D-glucose 
2.1.5.3 Cell	culture	Media	
2.1.5.3.1 Neurosphere preparation and maintenance 
2.1.5.3.1.1 Solution1 
10% HBSS 
1.8% Glucose 
Diluted in ddH2O with final pH 7.5 
2.1.5.3.1.2 Solution2 
30% sucrose dissolved in 0.5x HBSS with pH7.5. 
2.1.5.3.1.3 Trypsin inactivating solution (Solution3) 
4% BSA  
20mM HEPES 
Diluted in EBSS with a final pH 7.5 
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2.1.5.3.1.4 Dissection medium 
1.33mg/ml trypsin  
0.7mg/ml hyaluronic acid  
Trypsin and hyaluronic acid are dilute in a Solution1 
2.1.5.3.1.5 Adult neurosphere Medium 
8mM HEPES 
1% penicillin/streptomycin 
2% B27 
10ng/ml EGF/FGF2 
Diluted in DMEM:F12 (GlutaMAX) 
2.1.5.3.1.6 Embryonic neurosphere Medium 
1% D-glucose 
1% penicillin/streptomycin  
2% B27 
0.2% EGF andFGF2 
Diluted in DMEM: F12 (GlutaMAX) 
2.1.6 Cell	lines	
In this work are used different cell lines for various purposes. These are recorded 
below. 
Bacterial cell lines:  
• DH5α Competent E.Coli (Invitrogen- Life Technologies) 
• DB 3.1, ccdB resistant, Competent  E. Coli (Invitrogen- Life Technologies) 
Eukaryotic cell lines: 
• P19 carcinoma cells (kindly provided by Dr. Francois Guillemot) 
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2.1.7 Cloning	and	expression	plasmids	
Plasmid Origin 
164-pENTR1A Kindly provided by Dr. Alexandra Lepier 
311-pCAGGS-Dest Kindly provided by Dr. Alexandra Lepier 
374-pLV(CAG)-Dest-GFP Kindly provided by Dr. Alexandra Lepier 
pCAGCre Shitamukai et al. 2011 
pCAG-Floxp-mKO2-F Shitamukai et al. 2011 
pCAG-GFP-DEST Kindly provided by Dr. Paolo Malatesta 
pCAG-HJURP-GFP Stefania Petricca 
pCAG-Leca2-GFP Tessa Walcher  
pCAG-Leca4-GFP Tessa Walcher  
pCAG-Pax6-GFP Kindly provided by Dr. Robert Blum 
pENTR6-GW-grandestuffer  Kindly provided by Dr. Paolo Malatesta 
pmiRNA-1202 Stefania Petricca 
pmiRNA-946  Stefania Petricca 
 
2.1.8 Primary	antibodies	
Following is the list of primary antibodies used for immunostaining. 
Antigen 
Species-
Isotype 
Company Catalog # Dilution Treatment 
Anti-5-bromo-2'-
deoxyuridine 
(BrdU) 
Rat Abcam AB6326 1:200 
HCl 
treatment 
Anti-Acetylated 
Tubulin 
mouse 
IgG2b 
Sigma 
Aldrich 
6-11B-1 1:500   
Anti-Activated 
Caspase3 
rabbit Millipore AB3640 1:200   
Anti-Doublecortin 
(Dcx) 
guinea pig Millipore AB2253 1:1000   
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Anti-Glial fibrillary 
acidic protein 
(GFAP) 
rabbit Dako Z0334 1:500   
Anti-Glial fibrillary 
acidic protein 
(GFAP) 
mouse IgG1 
Sigma 
Aldrich 
G3893 1:1000   
Anti-Green 
Fluorescent Protein 
(GFP) 
Chick Aves Labs GFP-1020 1:1000   
Anti-Holliday 
Junction 
Recognition 
Protein (HJURP) 
rabbit 
Sigma 
Aldrich 
HPA00843
6 
1:250   
Anti-Paired box 
protein6 (Pax6) 
rabbit Millipore AB2237 1:500   
Anti-Paired box 
protein6 (Pax6) 
mouse IgG1 Abcam ab78545 1:200   
Anti-Phospho 
Histone H3 (Ser10) 
rabbit Millipore 06-570 1:200   
Anti-
Phosphorilated 
Vimentin (Ser55) 
mouse 
IgG2b 
MBL D076-3 1:100   
Anti-T-box brain 
protein 2 (Tbr2) 
Chick Millipore AB15894 1:500   
Anti-β-III-Tubulin 
mouse 
IgG2b 
Sigma 
Aldrich 
T8660 1:500   
2.1.9 Primers	used	for	qPCR	analysis	
Below are catalogued the primers used to evaluate the levels of specific genes via 
qPCR. 
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Primer Sequence 
Paired forward CAGCTTGGTGGTGTCTTTGT 
Paired reverse GCAGAATTCGGGAAATGTCG 
Splice forward GCAGATGCAAAAGTCCAGGT 
Splice reverse CTCGTAATACCTGCCCAGAA 
Homeo forward TCTAATCGAAAGGGCCAAATG 
Homeo reverse AGGAGGAGACAGGTGTGGTG 
Bub1 forward AGCATGAGCAGTGGGTTAGT 
Bub1 reverse TCCTGCTGGGAGCAAGTATT 
Bub1 forward_2 GCATGAGCAGTGGGTTAGTG 
Bub1 reverse_2 TTCCTGCTGGGAGCAAGTAT 
HJURP Forward GCCCCAGGGGTTGAGAGTTT 
HJURP Reverse  TAAGCTCGTATCCGCACCGC 
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2.2 Methods	
2.2.1 In	vivo	methods		
2.2.1.1 Mouse	lines	
All the animals used in this work were kept in the animal facility of the Helmholtz 
Zentrum München. All the experimental procedures were performed in accordance 
with German and European Union guidelines. Animals are maintained on a 12h light-
dark cycle. The day of the vaginal plug is considered as embryonic day 0 (E0) and the 
day of birth as postnatal day 0 (P0). In this study, except when specifically expressed, 
the Pax6
Leca2
 mouse line (Thaung et al., 2002) is used.  
This line was originally obtained from the GlaxoSmithKlein research. 
Animals were crossed two generation with the CD1 wild type strain and afterwards 
maintained by interbreeding (original background: 129S6). Currently animals are 
backcrossed to C3HeB/Fej background (3
rd
 generation). 
Characteristic of the mouse line used in this work: 
 
Name Symbol Mutation description Mouse strain 
Paired box 6; lens 
corneal adhesion 2 
Pax6
Leca2
 
Chemically induced (ENU) Single 
point mutation (C586T RED 
domain)  
Original Background:129S6  
crossed 2 generations with 
CD1WT and maintained by 
interbreeding 
2.2.1.2 Anesthesia	
To perform in utero operations, mice are anaesthetized by intraperitoneal injection of 
a “Sleep” solution containing: Fentanyl (0.05 mg/kg), Midazolam (5 mg/kg) and 
Medetomidine (0.5 mg/kg). The anaesthesia is terminated with a subcutaneous 
injection of an “Awake” solution composed of: Buprenorphine (0.1 mg/kg), Atipamezol 
(2.5 mg/kg) and Flumazenil (0.5 mg/kg). 
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To perform transcardial perfusion, juvenile and adult animals are anesthetized with an 
intraperitoneal injection of Ketamine (Ketamine hydrochloride 100μg per gram of 
bodyweight) and Rompun (Xylazinhydrochloride, 20μg per gram of bodyweight) 
prepared in 0.9% NaCl solution (Braun). 
2.2.1.3 In	utero	electroporation	
Surgeries were performed on animals in accordance with the guidelines of 
Government of Upper Bavaria under licence number 55.2-1-54-2532-79/11.  
E13 pregnant females are anesthetized as described in the section above and operated 
as previously described in (Saito, 2006). In brief, the shaved abdomen is opened by 
caesarian section in order to expose the uterine horns. These are kept wet and warm 
by continuous application of pre-warmed saline. Endotoxin free plasmids -diluted to 
1µg/µl- are mixed to Fast green (2.5 mg/μl, Sigma). 1µl of mix is injected into the 
ventricle with the aid of glass capillaries (self-made with a micropipette puller). 
DNA is electroporated into the telencephalon (dorsal or ventral according to the 
orientation of the electrodes) with four pulses of 38mV and 100ms. At the end of the 
electroporation, the uterine horns are repositioned into the abdominal cavity, which is 
then filled with pre-warmed saline. The abdominal wall is then sewn closed by surgical 
sutures with medical sewing equipment. Anaesthesia is terminated as described above 
and animals are monitored while they wake up and recover from anaesthesia. 
The day after (E14), operated animals are anesthetized with CO2 and sacrificed by 
cervical dislocation. Embryos are placed into HBSS (Hank’s Balanced Salt Solution -
Gibco, Life Technologies-) supplemented with 10mM Hepes (Gibco, Life Technologies). 
Embryos are dissected and brains are fixed; used for FACS sorting or used for ex vivo 
life imaging. 
2.2.1.4 Fixation	of	embryonic	mouse	brain	and	cryosectioning	
Embryonic brains are fixed in 4% Paraformaldehyde (PFA) with gentle rotation at 4°C 
for 1,5-6h (E10/E12: 1,5h; E14: 2h; E16: 4h; E18: 6h). Brains are then washed with PBS 
and cryoprotected in 30% sucrose (diluted in PBS) overnight followed by embedding in 
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Tissue-Tek and frozen on dry ice. Tissue is then stored at -20 °C until it is cryosectioned 
in 20-30μm slices with a Cryostat (Leica). 
2.2.1.5 Ex	vivo	live	imaging	
To perform ex vivo live imaging Pax6
Leca2
 embryos are electroporated in utero as 
described before (section 2.2.1.3) and the embryos processed the day after (E14). 
Briefly to the procedure: the pregnant mother is sacrificed by cervical dislocation at 
day E14 and the uterus with the embryos is placed in the ice cold dissection medium. 
After dissection of the brains, with consequent removal of the meninges, the brains 
are transferred into a plate with low melting agarose at 42°C. 
The brains are then oriented with the olfactory bulb facing the operator and the plate 
left in ice to solidify. 
The blocks of agarose containing the brains are then fixed on the vibrotome support 
(Leica) using the Roti Coll I (Carl Roth) and cut in 300µm tick sections. 
The sections are then cleaned of the excess of agarose and embedded in collagen 
matrix. 
The slices embedded in the matrix are finally placed onto the filter (cell culture insert; 
Millicell PICMORG50) and the plate is put in the incubator (37°C, 5%CO2) for 10 min to 
allow the collagen to solidify and only at that point the culture medium is added. 
The slices are then incubated for at least 30min in order to stabilize the whole culture 
system and minimize movements during the movie acquisition. 
The movie is performed using a confocal microscope Olympus FV1000 cLSM system 
(Olympus), using the FW10-ASW 4.0 software (Olympus). 
Images are acquired every 15min for about 24h. 
Data processing and analysis are performed with Fiji software, an open source image 
processing package based on ImageJ (Schindelin et al., 2012). 
2.2.1.6 BrdU	administration	
In adult mouse, 100mg/kg bodyweight of DNA base analogue 5 bromodeoxyuridine 
(BrdU) is injected intraperitoneally 1h before sacrifice to label fast proliferating cells. 
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BrdU is dissolved at a concentration of 10mg/ml in sterile 0.9 % NaCl solution (Braun) 
by continuous stirring at 37°C for 2h. 
2.2.1.7 Fixation	of	adult	mouse	brain	and	sectioning		
Adult animals are anesthetized by intraperitoneal injection as previously described 
(section 1.2.1.2). They are transcardially perfused first with a PBS in order to clean up 
the circulation from the blood and afterwards with 4% PFA as fixative. The fixed brains 
are then removed and post fixed in 4% PFA overnight at 4°C in continuous rotation. 
After post fixation, brains are washed in PBS for a few hours and embedded in 3% 
agarose diluted in PBS. After the agarose hardened, brains are sliced with a vibrotome 
(Zeiss) at thickness of 70-100µm and collected in PBS. 
2.2.1.8 Ex	vivo	SEZ	explant	preparation	
To assess the migratory ability of neuroblasts (cells located in the lateral wall of the 
SEZ characterized by the capacity to migrate via the RMS to the OB) of postnatal 
animals, explant of the SEZ were taken out from P15 animals and cultured for 7div. 
The procedure implies that P15 animals are sacrificed by cervical dislocation and the 
brain dissected. 
The SEZ is isolated as described before in (Fischer et al., 2011) and the explants are 
made according to the guidelines proposed in (Gierdalski et al., 2011) 
Briefly, explants of the diameter of about 0.5mm (using Harris Uni-Core) are moved 
from ice cold dissection medium (1xHBSS supplemtend with 10mM HEPES), into a drop 
(0.25-0.5ml) of ice cold Matrigel. Using a 20µl pipette tip (kept on ice to avoid that the 
Matrigel sticks on it) the explants are posed on a glass coverslip and let seed for 5 min 
at room temperature. The explants are then covered with additional 30µl of Matrigel 
and let it set in the incubator at 37°C for 15min. 
Finally 2ml of explants culture medium is added to the explants.  
The explant are then incubate at 37°C in 5%CO2, 95%O2 for 3 days, time in which the 
migratory behavior is analyzed. 
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2.2.2 Methods	in	cell	biology	
2.2.2.1 Cell	culture	
2.2.2.1.1 Preparation of coated coverslips 
Glass cover slips are washed with acetone and boiled in ethanol containing 0.7% HCl 
for 30min. After two washing steps in 100% ethanol, these are dried at RT and 
autoclaved for 2h at 180°C. To each well of a 24-well plate one sterilized cover slip is 
added and pre-wetted with PBS. The PBS was replaced by 1% poly-D-lysine (PDL) 
dissolved in PBS or 1% Poly-dL-Ornithine (PORN) dissolved in water and plates are 
incubated for at least 2h at 37°C.  
The wells are washed three times using autoclaved ultrapure water. The PDL coated 
plates are left drying for 2h in the laminar flow before being transferred to the fridge 
and stored at 4°C until needed; on the PORN coated plate, Laminin (dissolved in water) 
is directly put on them and left for about 3h before use.  
2.2.2.1.2 Adult neurosphere preparation 
Adult animals are scarified by cervical dislocation and decapitated. The skull is opened; 
the brain dissected and collected in ice-cold HBSS containing 10mM HEPES. The adult 
subependymal zone (SEZ) is dissected out as described before in (Fischer et al., 2011). 
Afterwards the tissue is incubated in the dissociation solution at 37°C for 15min and 
after gentle trituration, incubated for another 15min. In order to inactivate trypsin 
Solution 3 is added and cells are passed through a 70μm cell strainer. Next cells are 
centrifuged at 1300rpm for 5min and suspended in Solution2. Another centrifugation 
step follows at 2000rpm for 10 min. The cell pellet is suspended in 2ml of Solution3, 
added on top of 10ml of cold Solution3 and centrifuged at 1500rpm for 7min. Finally, 
cells are suspended in adult neurosphere medium. The cell concentration is 
determined by Trypan Blue dye exclusion and primary sphere forming cells are seeded 
at a cell density of 5-10cells/μl. 
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Flasks containing the floating cells are incubated at 37°C with 95%O2 and 5% CO2. 
Every second day, fresh EGF and FGF2 are added. 
Cells are passaged three times before differentiation. The passaging takes place once a 
week by centrifugation at 1200rpm for 5min, followed by enzymatic dissociation 
(0.05% trypsin [EDTA]) and re-plating in 50% neurosphere conditioned medium and 
50% fresh adult neurosphere medium. From the second passage on, cells are seeded 
at a clonal density of 1cell/μl.  
To differentiate the neurosphere forming cells after the third dissociation step (third 
passage) 200.000 cells per well are plated in a 24 well plate (PDL coated) in 1ml of 
adult neurosphere medium. After 2h from plating, cells are virally transduced and left 
in their medium for 7days before analysis. 
2.2.2.1.3 Embryonic neurosphere 
E14 embryos are removed from the mother and collected in ice-cold HBSS containing 
0.01M HEPES. The brains are dissected out with careful removal of the meninges. 
Dorsal telencephalon is cut as well as the ganglionic eminence but separated from the 
olfactory bulb and the hippocampal anlage. Cortices and GEs are kept in separate 
tubes filled with ice cold HBSS. The tissue is then allowed to settle; the balanced salt 
solution is replaced by 1ml 0.05% trypsin (EDTA) and incubated for 15min at 37°C. 
Afterwards 2ml of DMEM (4.5g glucose, GlutaMAX) supplemented with 10% FCS and 
1% penicillin/streptomycin, is added in order to block the enzymatic activity. The 
tissues are then mechanically dissociated with a fire polished Pasteur pipette coated 
with serum and centrifuged for 5min at 1200rpm. 
The pellet cells are then cultivated in flask in embryonic neurosphere medium. 
The neurosphere are passaged 3 times for three consecutive weeks. After the third 
passage, the cells are allowed to seed, on PDL coated dishes and let them differentiate 
in neurophere medium and normally 2h after plating the cells were transduce with 
different viral constructs. 
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2.2.2.1.4 P19 cells cultivation 
P19 cells (embryonic carcinoma cell line derived from an embryo-derived 
teratocarcinoma in mice) are cultivated as described next. 
Medium  
• DMEM (Dulbecco’s Modified Eagles Medium)  
• 10% FCS  
• 1% Penicillin/Streptomycin 
• 1% MEM Non-Essential Amino Acids Solution (Life Technology) 
The cells are cultivated at 37°C and 5% CO2, 95% O2. They are passaged when they 
reach the confluence of 80%.  
For passaging, cells are washed with sterile 1xPBS once, and let detach with 2ml of 
Trypsin-EDTA for 1-2min at 37°C. The detached cells are re-suspended in 2ml fresh 
growth medium until a single cell suspension is present. Aliquots (1/20-1/3) of the re-
suspended cells are plated on Petri dish containing 10ml fresh medium and equally 
distributed by gentle shaking. 
2.2.2.1.5 Cell time lapse imaging 
Live imaging of dissociated cultures (2.2.2.1.2,2.2.2.1.3) or from P19 cells (2.2.2.1.4) is 
performed with a cell observer (Zeiss) at a constant temperature of 37°C and 5% CO2. 
Phase contrast images are acquired every 10min for 2-7 days, according to the type of 
culture, using a 20x phase contrast objective (Zeiss) and an AxioCamHRm camera with 
a VBA module remote controlling Zeiss AxioVision 4.7 software (Rieger and Schroeder, 
2009). Single-cell tracking is performed using a custom made computer program 
(TTT)(Rieger and Schroeder, 2009). Movies are analyzed using the TAT player from the 
TTT software and assembled using the open source imaging software Fiji (Schindelin et 
al., 2012). 
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2.2.2.2 Immunostaining		
Immunohistochemistry (immunostaining performed on fixed tissue) and 
immunocytochemistry (immunostaining performed on cell culture sample) are 
performed with the primary antibodies listed in paragraph 2.1.8 diluted in a solution 
containing 0.5% TritonX in PBS and 10% NGS (Normal Goat Serum). 
In general, primary antibodies are applied overnight at 4°C in humidified chambers to 
avoid evaporation of the staining solution. Afterwards the cells coverslips or the tissue 
slices are washed with PBS prior the application of the secondary antibody staining 
solution for 2h at room temperature. To visualize cell nuclei, DAPI (4', 6-diamidino-2-
phenylindole) is included in the solution with a concentration of 0.1µg/ml. 
The secondary antibodies used are isotype specific antibodies conjugated to Alexa-488, 
Alexa-543, Alexa-633 (dilution 1:1000 in staining solution –Invitrogen, Life 
Technologies-) or Cy2, Cy3, Cy5 (dilution 1:500 in staining solution -Jackson Immuno 
Research-). 
As last step, cells and sections are again washed in PBS and mounted with Aqua 
Poly/Mount, a mounting medium that enhances and retains fluorescent stains.  
The mounted samples are kept for long storage at room temperature. 
Some antibodies required a specific pre-treatment to retrieve the antigen.  
In particular for the anti- BrdU antibody the HCl pretreatment is required. This consists 
of a 30min incubation of the samples at room temperature with 2N HCl and two 
consequent washing for 15min each with 0.1M sodium-tetraborate. 
All the antibodies used, together with the working concentration and the treatment 
conditions are listed in the section 2.1.8. 
2.2.2.3 Image	acquisition	and	processing	
Immunohistochemistry images are acquired with an Olympus FV1000 cLSM system 
(Olympus), using the FW10-ASW 4.0 software (Olympus). The system is equipped with 
laser diodes 405nm, 559nm and 635nm. Colour adjustments are performed in the 
acquisition software, or using the open source imaging software Fiji (Schindelin et al., 
2012). 
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2.2.2.4 Transfection	of	cells	
The Lipofection, also called liposome transfection, is used to be able to introduce 
specific genetic materials into cells. To do so cells are plated on 6 well dishes (when 
need form RNA or protein extraction) or 24 well dishes (in case of transfection prior to 
2D-imaging) at 30-40% confluency the day before transfection in 2ml total volume. 
Before transfection, growth medium is collected and replaced with OptiMEM. Cells are 
transfected with Lipofectamine2000 according to the protocol of the manufacturer. 
2μg of plasmid DNA is used per well in a 6 well dish format and 1μg is used per well of 
a 24 well dish. 2-4 hours after transfection, OptiMEM is replaced by growth medium. 
Reporter expression was generally visible 12-16 h later. 
2.2.3 Methods	in	molecular	biology	
2.2.3.1 Mouse	tail	DNA	extraction	
Parental animals are maintained in a heterozygote allelic state and crossed to obtain 
all three possible genotypes (WT/WT; WT/-; -/-) from the same litter. 
To sort out the different genotypes in the Pax6
Leca2
 colony, the homozygote mice are 
distinguished by eye phenotype whereas wild type and heterozygote mice are 
genotyped by PCR followed by sequencing on tail DNA. 
In details, 1-3mm long tails from ear marked mice (4-5 weeks old) are incubated 
overnight at 55°C in 300µl of Lysis Buffer supplemented with 2µl of Proteinase K 
(1mg/mL) in order to digest contaminating proteins and inactivate nucleases in the 
nucleic acid preparation. 
The following day, the samples are cooled down to room temperature with the 
addition 100µl of protein precipitation solution. Samples are then vortexed and 
centrifuged at 13000rpm to remove hairs and tissue residues. The supernatant is 
poured in 300µl of Isoporapanol and mixed by inverting. The precipitate is then 
washed with 300µl of 70% ethanol and dissolved in 50µl of DNA hydration solution 
(Qiagen) and purified DNA is dissolved at 65°C for 1h. 
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2.2.3.2 PCR	genotyping	
Pax6
Leca2
 colony is genotyped with a standard PCR mix (Qiagen kit) containing 1nM of 
each required primer (Pax6Leca2 forward primer: TCCAGGATGGCTGGGAGCTT; 
Pax6Leca2 reverse primer: TTGCGTGGGTTGCCCTGGTA); 1nM of dNTPs (dATP, dCTP, 
dGTP, dTTP); 0.5µl of MgCl2; 1.5U of Taq DNA polymerase; 2.5µl of 10X PCR buffer and 
2µl of genomic DNA (dilution1:10 in H2O) with a final volume of 25µl per reaction. The 
DNA is amplified under these cycling conditions: 
94°C 2min 
30x 94°C 50sec 
57°C 50sec 
  72°C 50sec 
72°C 5min 
16°C ∞ 
2.2.3.3 Sequencing	
To be able to genotype the colony, characterized by the presence of a single point 
mutation, it is necessary to sequence the Pax6 RED domain to localize the mutation. To 
do so, consequently to the first PCR, the products need to be cleaned. The 295bp 
amplicone is purified using the QIAquick Gel Extraction Kit (Qiagen) according to the 
instructions of the manufacturer. A second PCR is then run using 0.5µl of Big Dye 
Terminator (containing the polymerase); 2µl of Big Dye Buffer; 0.5µl of Primer sense or 
antisense (from 100µM stock) and 2µl of DNA template with a total of 5µl PCR reaction 
volume. 
The sequencing PCR is then performed according to the following cycling conditions: 
96°C 1min 
35x 96°C 10sec 
50°C 5sec 
  60°C 4min 
16°C ∞ 
 
The sequencing PCR is then purified using Dye Ex 2.0 Spin Kit (Qiagen) according to the 
instructions of the manufacturer and filled in a sequencing plate. 
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The sequencing is performed at the Sequencing Core Facility of the Helmholtz Zentrum 
München and the sequence analyzed with the use of the free available software ApE 
(A plasmid Editor by Wayne Davis). 
2.2.3.4 RNA	extraction	
The total RNA for qPCR analysis was extracted from cortices and lateral ganglionic 
eminences of WT and Pax6
Leca2-/- 
littermates in different developmental stages in order 
to evaluate the expression of the two isoforms of Pax6 and confirm Microarray data 
from previous study (Walcher et al., 2013). 
The RNA derived from P19 cell lines was also used in order to evaluate gene expression 
changes upon overexpression of different forms of Pax6 and HJURP at different time 
points after overexpression. 
In all the cases the RNA was extracted using RNeasy Mini Kit (Qiagen) according to the 
protocol suggested by the manufacturer. 
2.2.3.5 Determination	of	the	concentration	and	quality	of	nucleic	acids	
The concentrations of nucleic acids are determined using the Nanodrop (NanoDrop 
1000 Thermo Scientific. The ratio of absorbance at 260 nm and 280 nm is used to 
assess the purity of DNA and RNA. A ratio around 1.8 is generally accepted as “pure” 
for DNA; a ratio around 2.0 is generally accepted as “pure” for RNA. 
The quality of RNA was further assessed by using the Agilent Bioanalyzer (Agilent 2100 
Bioanalyser). Agilent Bioanalyzer creates electrophorograms measuring the abundance 
of ribosomal 5S, 18S, and 28S RNAs. This also assigns RNA Integrity Number (RIN) that 
ranges from 1 (totally degraded RNA) to 10 (completely intact RNA). For Real Time PCR 
were used high quality RNA samples (RIN > 7). 
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2.2.3.6 cDNA	synthesis	and	quantitative	PCR	analysis	
The cDNA is synthetized from the total RNA extracted (500ng/µl) using the Maxima 
First Strand cDNA Synthesis Kit (Thermo Scientific) according to the instructions of the 
manufacturer. 
The qPCR is performed using a QuantStudio™ 6 Flex Real-Time PCR System (Life 
Technology), gene specific primers listed above in the section 2.1.9, and the SYBR 
green master mix (Qiagen). GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) is 
used as reference gene for normalization of the expression of the target gene. The 
relative expression of each mRNA is calculated using the delta Ct method between the 
gene of interest and the reference gene:  
( = ∆	
). 
Following the cycling conditions: 
 
Hold stage 
  95°C 5min 
PCR stage     
40x 95°C 10sec 
  60°C 30sec 
Melt curve stage     
95°C 15sec 
60°C  1min 
95°C 15sec 
2.2.3.7 Cloning	
In order to overexpress the HJURP, its cDNA (Source BioScience) (first confirmed for 
the correct sequence upon sequencing) was cloned into the pENTR1A vector by 
sequential digestion with the restriction enzymes SalI and NotI. Finally the HJURP cDNA 
was shuttled into the pLVCAG-GFP destination vector by LR reaction (Gatway system). 
The resulting plasmid was checked by sequencing. 
To achieve the knock down of the HJURP gene, the RNAi technology was used by 
designing miRNA against the gene of interest using the BLOCK-iT™ RNAi Express tool 
(Life Technology). 
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The double stranded oligos were generated according to the protocol of the 
manufacturer. The two miRNAs (HJURP946 and HJURP1202, according to the designing 
coordinates) were cloned into the pENTR6_GW_grandestuffer and finally shuttled into 
the pDest-311 vector by LR reaction (Gateway system). 
2.2.3.7.1 Transformation into chemically competent E.Coli 
The amplification of a specific plasmid is achieved inserting it into chemically 
competent cells. The insertion of exogenous genetic material into a bacterial cell 
happens by a process called transformation.   
To perform a transformation the following materials are needed: 
• LB-medium 
• Chemo-competent E.coli  
• Bacterial agar plates  
• Antibiotic: 
o Ampicillin stock (100 mg/ml): use 1:1.000  
o Kanamycin stock (50 mg/ml): use 1:1.000 
An aliquot of 50μl containing chemo-competent cells are thawed on ice. DNA (5-200 
ng) is added to it and incubated for 20min on ice. Cells are heat-shocked for 45s at 
42°C, and cooled on ice for 2min. 200μl LB medium is added and cells are incubated for 
45min at 37 °C on a roller shaker. Afterwards, different aliquots are plated on bacterial 
agar plates (50-500μl) and incubated overnight at 37°C. 
2.2.3.7.2 Bacterial liquid cultures and DNA purification 
For large scale (200ml) and small scale (5ml) liquid bacterial cultures, a single colony 
from the agar plate is inoculate into LB buffer, supplement with the appropriate 
antibiotic and incubated overnight at 37°C under vigorous shaking. 
Plasmid DNA is then isolated with Qiagen Maxi or Mini kits according to the instruction 
of the manufacturer. 
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2.2.3.7.3 Restriction digestion of DNA 
A restriction reaction is required to be able to cut DNA in specific region. This is 
prepared as described below: 
• 1µg DNA plasmid 
• 2µl 10xreaction buffer (NEB) 
• 5-10U restriction enzyme (NEB) 
• Up to 20µl of H2O 
The reaction is incubated at the appropriate temperature according to the restriction 
enzyme used and for a time that ranges from 2h to overnight. The DNA digestion is 
assessed by gel electrophoresis. 
2.2.3.8 Gel	electrophoresis	
To perform gel electrophoresis, an appropriate amount of Agarose to prepare 1-2% 
(w/v) gel, depending on the size of the nucleic acid of interest, is dissolved in 1X TAE 
buffer let to melt in a microwave. The solution is then cooled down and SYBR® Safe 
DNA Gel Stain (Life Technology) is added in 1:10000 dilution before pouring the gel in 
an electrophoretic chamber. After the gel solidified, DNA samples mixed with 6X 
loading dye and a DNA ladder of appropriate size is loaded and electrophoresis 
performed at 100-200V. Then the band patterns of the samples are documented under 
UV light. In case of further usage of the DNA fragments for downstream applications; 
the DNA fragments with the right size are cut under UV light (254nm), transferred into 
an Eppendorf tube and purified using the QIAquick gel extraction kit (Qiagen) 
according to the protocol of the manufacturer. 
2.2.3.8.1 Ligation 
In order to allow ligation, the insert of DNA is used in a 5-10 fold excess from the DNA 
vector. The ligation reaction is let at 16°C overnight and transformed the following 
day. Colonies are picked, DNA purified and the final vector analyzed by sequencing. 
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The sequencing is performed at the Sequencing Core Facility of the Helmholtz Zentrum 
München and the sequence analyzed with the use of the free available software ApE 
(A plasmid Editor by Wayne Davis). 
2.2.4 Data	analysis	
Quantifications of cells in mitosis (PH3+ cells) were performed at E14 and E16 across 
the entire LGE from lateral to medial using the Olympus Flow View software. All 
quantifications were done on images from ventral telencephalon using level matched 
sections of at least three stage matched embryos of each genotype. 
Quantifications of BrdU+ and Dcx+ cells in the adult brain were performed in P56 
sections and total numbers of the different categories defined per field of view. Fields 
of view are pictures taken with a 40x magnification 800*800 pixels. 2-3 sections per 
animals were measured of at least three staged matched animals of each genotype. 
2.2.4.1 Statistics	
Calculation of the arithmetic average: 
̅ = 1


 
Standard deviation (SD): 
 = ∑  − ̅
 − 1  
Standard error of the mean (SEM): 
σ	 = √ 
were performed with GraphPad Prism5 and the same software used to test statistical 
significance. Data were considered as significant with P≤0.05 (*), very significant with 
P≤0.01 (**) and highly significant with P≤0.001 (***). 
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3 Aim	of	the	thesis	
Neural stem cells proliferation, specification and differentiation are three processes 
that need to be tightly regulate in order to allow the production of specific neuronal 
subtype at the right time and place in the brain during development and in the 
neurogenic regions at postnatal stages. 
The transcription factor Pax6 is one of the factors able to orchestrate all these 
functions. It is defined as master regulator, being implicated in the control of fate 
determination and cell proliferation (Osumi et al., 2008; Georgala et al., 2011a). To 
control these aspects of the neurogenic process, Pax6 utilizes the paired (PD) DNA 
binding domain (Haubst et al., 2004; Ninkovic et al., 2010). 
The PD domain is structured in a modular bipartite manner with two subdomains PAI 
and RED that bind cooperatively and independently to different binding sites. Both 
these subdomains exert effect on neurogenesis and on the control of cell proliferation 
(Walcher et al., 2013). 
Given these evidences this work is aiming to dissect the molecular network controlled 
by the PD domain which is involved in the regulation of the cell cycle progression. 
Particular attention is given to the RED subdomain and how it affects the progenitors 
of the ventral telencephalon in the lateral ganglionic eminence (LGE). 
In this work will be also explored the influence of the RED subdomain of Pax6 on the 
neurogenic lineage progression in the subependymal zone (SEZ), the postnatal 
neurogenic region laying at the ventricular surface, which is originating from the 
developing LGE. 
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4 Results	
The transcription factor Pax6 is a pivotal gene in the central nervous system 
compelling, among other functions, for the proper patterning of the brain during 
development (Stoykova et al., 1996; Stoykova et al., 2000; Toresson et al., 2000). 
Pax6 is highly expressed in the developing cortex (Walther and Gruss, 1991; Gotz et al., 
1998; Heins et al., 2002), delineating the major border between the dorsal and the 
ventral forebrain with the pallial-subpallial boundary (PSPB). 
In the ventral telencephalon, although at lower level if compared with the dorsal 
forebrain, the Pax6 protein is expressed in the lateral ganglion eminence (LGE) 
(Hallonet et al., 1998). Additionally in the ventral most side of the forebrain it is 
expressed in the amygdaloid complex (Tole et al., 2005) and in the latero-cortical 
stream (Carney et al., 2006), but these two areas will not be further discussed. 
To address the contribution of the RED domain of the Pax6 protein in the regulation of 
the proliferation mode of the progenitors cells located at the ventricular surface, we 
took advantage of the Pax6
Leca2
 mutants harboring a single point mutation in the RED 
DNA binding domain which is predicted to abolish its binding activity. 
In this chapter will be underlined the role of the RED domain in regulating cell division 
of progenitor cells and the repercussion of such regulation on the postnatal brain. 
4.1 Pax6	in	the	lateral	ganglionic	eminence	
4.1.1 Pax6	isoforms	expression	in	the	developing	telencephalon		
In vertebrate the Pax6 locus encodes for three different protein isoforms: the 
canonical form, the Pax6(5a) and the PD-less form. The Pax6 PD-less form is expressed 
higher than the other two isoforms early in development (E10-E12), but it decreases at 
the onset of neurogenesis when the PD-containing forms play the major roles (Haubst 
et al., 2004). 
The levels of expression of the two PD-containing forms of Pax6 are different between 
the dorsal and the ventral region. Pax6 and Pax6(5a), consisting of an insertion of 14aa 
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in the paired (PD) binding domain (Figure 12A-B), are expressed higher in the cortex 
than in the LGE and this difference in expression in maintained during development at 
E14 and E16 (Figure 12 C-D). Moreover, the levels of expression of the two forms of 
Pax6 tent to decrease as neurogenesis declines in both cortex and LGE (Figure 12D). 
During early development the canonical Pax6 and the isoform Pax6(5a) are expressed 
in a ratio 8:1 in favor of the canonical Pax6 (Kozmik et al., 1997; Pinson et al., 2006). In 
the cerebral cortex, the ratio between the two transcripts is around 3:1 at the 
midneurogenesis (E14) and 2:1 at later time points (Figure 12C-D) always in favor of 
the canonical form of Pax6. In the LGE of the ventral telencephalon the two transcripts 
are equally expressed at midneurogenesis but this ratio increases at the later time 
points during brain development, in favor to the canonical Pax6 (Figure 12 C-D). 
The proportion of the two PD-containing forms of Pax6 is maintained in favor of the 
Pax6 canonical form also in mutant conditions (Figure 12 E). 
In the cortex of the Pax6
Leca2
 mutants which harbor a mutation in the RED subdomain 
of the PD (Figure 12 E), the mRNA expression levels of Pax6 and its isoform Pax6(5a) 
have been measured in the mutant cortex and compared to the wild type (WT). In this 
case, even if the levels of Pax6 and Pax6(5a) in the mutant cortices are increased if 
compared with the WT levels of the same mRNAs, probably due to the fact that the 
inactivity of the RED subdomain disrupts any auto-regulatory loop of Pax6, the 
proportion between the two forms of Pax6 is preserved. This suggests that if the 
expression of the two isoforms of Pax6 is regulated in a region specific manner, this is 
independent on target genes recognized by the RED domain of Pax6. 
Results 
53 
 
 
Figure 12: Pax6 isoforms expression in the cortex and in the LGE 
(A-B) Scheme depicting two isoforms of the Pax6 protein present in the developing brain. (A) Canonical form 
prevalent in the developing brain and the (5a) isoform (B) consisting of an insertion of 14aa in the PD DNA binding 
domain impairing the binding capacity of the domain itself. 
(C-D) mRNA expression level measured via qRT-PCR of the two isoforms in the dorsal and ventral telencephalon at 
E14 in (C) and at E16 in (D). (E)Histogram depicting the expression levels of the canonical form of Pax6 and the 
Pax6(5a) isoform in the cortex of WT and Pax6Leca2 The ratio of expression of the Pax6 vs Pax6(5a) in Ctx of E14 WT 
and Pax6Leca2. Data are shown as mean ± SEM of the relative expression of Pax6 and Pax6(5a) normalized to 
GAPDH (R=1/2-(ΔCt) ΔCt values have been measured for 3 independent samples of E14 and E16 brains). Significance 
defined via Unpaired TTest two-tailed pvalues. ns: non-significant; **P<0.01; *P<0.05. 
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4.1.2 Proliferation	of	progenitors	in	Pax6	RED	domain	mutants	
Pax6 controls the proliferation of progenitors during the development of the cortex 
and the PD domain at the N-terminus is determinant for such function (Warren et al., 
1999; Estivill-Torrus et al., 2002; Haubst et al., 2004). 
As previously mentioned, Pax6 expression is not only constrained in the cortical area 
but also expressed in the LGE of the ventral telencephalon. To assess the role of Pax6 
in controlling the proliferation of the progenitors in the LGE, I analyzed the number of 
phospho-histone 3 (PH3)-positive cells in Pax6
Leca2
 mutants compared to their age 
matching siblings. 
The antibody PH3 labels cells in the G2/M phase of the cell cycle, allowing the 
localization of actively dividing cells (Hendzel et al., 1997). While in the cortex PH3-
positive cells are mostly located in apical positions (the basal division represent around 
25% of the total PH3 positive cells (Pilz et al., 2013)), in the LGE around 60% of 
progenitors divide in non-apical position (Pilz et al., 2013). These non-surface mitoses 
are located within 10 rows of cells from the ventricular side (subapical progenitors SP) 
and in more basal positions (basal progenitors BP) (Figure 13). 
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Figure 13: Proliferating cells in LGE 
Scheme depicting the position of dividing progenitors in the lateral ganglionic eminence of the ventral 
telencephalon classified as apical progenitors (AP) dividing at the ventriclular surface; subapical progenitors (SP) 
dividing within 10 rows of cells from the ventricle and basal progenitors (BP) dividing more than 10 rows of cell 
away from the ventricle. 
 
In the mutant LGE the PH3-positive cells distribute similarly to the WT littermate and 
all the progenitors populations are represented (Figure 14 A-B). The mutation of the 
RED domain induces to the increase of mitoses in the population of the apical 
progenitors, the cells that divide at the ventricular surface (Figure 14 C-D). 
The increased number of PH3-positive AP cells is evident at E14 and then maintained 
at later times (E16), suggesting a constitutive effect due to the defective binding of the 
RED domain and not only a transient phenomenon. 
The increase in apically dividing progenitors is a common feature between the 
progenitors in the LGE and the progenitors in the developing cerebral cortex (Walcher 
et al., 2013). This suggests a common role for the RED domain in the regulation of the 
cell cycle independently from the region of origin of the cells. 
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Figure 14: Progenitor proliferation in Pax6
Leca2
 LGE 
(A-B) Micrographs of E14 ventral telencephalic sections depicting cells immunoreactive for phospho-histone H3 
(PH3) in Pax6
Leca2
 brains and their WT littermates. The insert shows a zoom of the ventricular area where the cells 
are mostly affected. Scale bars 50µm. (C-D) Histogram depicting the distribution of PH3+ cells in the LGE of E14 and 
E16 Pax6
Leca2
. Data are shown as mean ± SEM of the PH3+ cells per LGE length. Significance defined via Mann 
Whitney test. ns: non-significant;
**
P<0.01; 
*
P<0.05. E14 AP WT vs AP Pax6
Leca2
pvalue=0.019. E16 AP WT vs AP 
Pax6
Leca2
 pvalue=0.0031. n≥4 LGE sections per genotype, at least three different animals per genotype. 
 
The exclusive affection of the AP population in the Pax6
Leca2 
mutants resides on the 
fact that all the cells proliferating at the ventricular side express Pax6 (Figure 15). 
In the ventricular area (Figure 15) the phospho- vimentin (pVim) positive cells (marker 
used to label cells in the M-phase of the cell cycle homologous of PH3) are all 
expressing Pax6. This is different from the SP and BP where only some cells express the 
Pax6 protein. 
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In the populations of the SP and the BP the effect of the RED domain mutation might 
be diluted and masked in the analysis of the all non-apically proliferating progenitors. 
 
 
Figure 15: Pax6 expression in the progenitors of the LGE. 
(A-B) Micrographs depicting the expression of Pax6, in red, and pVim, in green, in WT (A) and in the mutant (B). in 
the high magnification examples of different progenitor co-immunostained with Pax6 and pVim (filled arrow heads) 
or expressing only pVim (outlined arrow heads). In green AP, in yellow SP and red BP. Scale bars 50µm. 
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4.1.3 Cell	death	analysis	in	RED	domain	mutants	
The increment of mitotic progenitors in the Pax6
Leca2 
is a general effect registered in 
the dorsal and ventral telencephalon. 
In the cortex the increase in PH3-positive apical progenitors upon the RED mutation 
has been explained as the effect of the Pax6 RED domain in controlling cells survival 
(Walcher et al., 2013). Pax6 is implicated to play a role in this context (Nikoletopoulou 
et al., 2007; Ninkovic et al., 2010). 
Supposedly this is a general effect exerted by Pax6 independently from the region of 
expression. In order to validate whether Pax6 RED domain is relevant for preserving 
progenitors survival, has been analyzed the level of apoptosis in the progenitors of LGE 
of the Pax6 mutants and their WT siblings. The immunostaining against activated-
Caspase3 was performed in the ventral telencephalon of E14 animals (Figure 16). 
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Figure 16: Survival of progenitors in Pax6
Leca2 
(A-B) Micrographs of E14 LGE depicting cells immunoreactive for activated-Caspase3 (green) in WT and mutants 
siblings. Scale bar 20µm. (C) Histogram depicting the number of activated-Caspase3 positive cells per total LGE. Data 
are shown as total number per 10 sections ±S.E.M. n (number of brains)≥3. *p<0.05; Mann-Whitney test. 
 
This analysis revealed that the mutation of the RED domain of Pax6 leads to a decrease 
of the cell survival in the LGE of the ventral telencephalon, similarly to the effect that it 
exerts on the progenitors of the developing cortex. 
This evidence, together with the increment of cells in mitosis (Figure 16 and Figure 14), 
suggested a direct involvement of the RED subdomain on the regulations of the mitotic 
progression that, if impaired, leads to cells aberrations and eventually cell death. 
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4.1.4 Cell	cycle	progression	in	Pax6Leca2	ventral	telencephalon:	loss	and	gain	
of	function	experiments	
In LGE of the Pax6
Leca2
 mutant animals, the increase in apically dividing progenitors and 
the reduction of cell survival could be explained by the AP cells failing in completing 
the cell cycle and the division of the two daughter cells during the last step of the 
cytokinesis. Failure in the cytokinesis would lead to the visualization of more nuclei, as 
in the analysis of fixed tissue where there is an increment of about 30% in PH3-positive 
cells (Figure 14), but those could be predicted as divided nuclei of daughter cells that 
did not completely cleaved their cytoplasm. 
To prove this hypothesis, we performed ex vivo live imaging of progenitor cells in the 
LGE. This technique offers the ability to follow single cells overtime during their cell 
cycle and allows answering if the abundance of mitotic figure in Pax6
Leca2
 is due to 
impairment in cytokinesis.  
 
Figure 17: Ex vivo life imaging: 
Scheme depicting the ex vivo live imaging paradigm as described in the method paragraph 2.2.1.5 
 
As described in the method paragraphs 2.2.1.3, 2.2.1.5, progenitor cells in the LGE are 
labelled via in utero electroporation (Figure 17) of embryos at E13. Three plasmids are 
introduced into the cells of the LGE of WT and mutant animals: 
• H2B-Venus is used to identify the nuclear movements since H2B is a member of 
the core histones that package DNA in the nucleus. 
• pCAG-Floxp-mKO2-F (Shitamukai et al., 2011) combined with a Cre expressing 
plasmid are used to highlight the cell membrane and to visualize the phase of 
the cytoplasmic scission. 
The day after the operation, embryos at E14 are sacrificed, sliced and imaged (Figure 
17). The imaging session is running for about 24 hours to be able to visualize at least 
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one cell division. The cell cycle of an apical progenitor cells is in fact lasting about 25h 
(Pilz et al., 2013). 
During this time was possible to monitor the progenitor cells during their division and 
estimate the time required for their nuclear and cytoplasmic division (example of time 
series in Figure 18). 
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Figure 18: LGE ex vivo live imaging 
(A-D) Micrographs depicting examples of cells in the WT (panel A-B, curtesy of Dr Sven Falk) and Pax6
Leca2 
(panel C-
D). Images are acquired with an interval of 15 minutes with a confocal microscope Olympus FV1000 cLSM system, 
20 x magnification ((A-B) 2x zoom as acquisition setting). (A-C) H2B-Venus used to visualize nuclear movements. (B-
D) mkO2 used to visualize the cytoplasm and cell membrane movements. Arrow heads indicate examples of the 
cells analyzed. 
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Figure 19: Time of cytokinesis definition and measuring 
(A) Scheme depicting the definition of “time of cytokinesis” measured as the time between the division of the 
nucleus and the full scission of the cytoplasm in two different daughter cells. (B) Dot blot representing the time that 
the cells analyzed need to divide into two daughter cells. Dots in black represent the WT cells measured (9 cells). 
The red dot represents the Pax6
Leca2
 cells that divided in the 150min of observation whereas the red triangles 
represent the cells that did not fulfill the requirement in the given time (cell1=510min: cell2=315min: cell3=150min; 
cell4=180min; cell5=255min). 
For the WT the horizontal bar represents the mean ±SEM. 
 
To prove the idea of a prolonged cytokinesis, we measured the “time of cytokinesis”. 
This is defined (Figure 19 A) as the time between the division of the nuclei, right after 
the condensation of the heterochromatin that is a synonym of the nuclear division 
initiation, and the full division at the membrane level of the two daughter cells. This 
analysis, (Figure 19 B) revealed that the time of cytokinesis in Pax6
Leca2
 mutants is 
longer than in the WT. Given an observation time of 150 minutes all the WT cells 
managed to complete division (average time: 82.8min) whereas only one Pax6
Leca2
 
completed the cytokinesis in the same time. 
These measurements could confirm that cells upon mutation of the RED domain have 
a prolongation of the time the cells share their cytoplasm after their nuclear division. 
This evidence was further consolidate when E14 brains, derived from Pax6
Leca2 
background, were analyzed and fixed after the electroporation of the same plasmids 
listed above (Figure 20). 
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Also via fixed analysis we could detect that the mutation of the RED domain is 
impairing the cell cycle progression of the apical progenitors of the LGE. The 
progenitors in the Pax6
Leca2
, even if composed by two nuclei (Figure 20), are still 
surrounded by a unique membrane. The situation in the WT is different (Figure 20 A), 
the cells are mostly in G phase with one nucleus ready to divide or differentiate. 
These data underline the importance of the RED domain of Pax6 in controlling the final 
step of the cell cytokinesis. 
 
 
Figure 20: Cell division in vivo 
Orthogonal projections depicting examples of radial glia cells after in utero electroporation of membrane protein in 
the mutant (B) and WT littermate (A) LGE. Scale bars A 20µm, B 10µm. 
 
The implication of the RED domain mutation affecting cell cycle progression and 
compromising the capacity of the cells to complete their mitosis was further supported 
by in vivo experiments. In these experiments we performed loss of the RED domain 
functions in the WT background. Cells in the WT brains were transduced with retroviral 
vectors co-expressing the Pax6
Leca2
 form and the GFP protein. The viruses were 
injected at the E14 stage and the brains analyzed 3 days later (E17). The injection was 
directed in the ventricle and labelled cells were found in the cortex. 
The cells found, even if they were only few probably due to the low titer of the virus, 
were all in duplets (Figure 21). 
This is considered an additional evidence that the mutation of the RED domain of Pax6 
would lead to impairments in the progression of the mitotic phase. 
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Figure 21: In vivo overexpression of the RED domain mutation of Pax6 
(A-B) Micrographs depicting duplets of cells in the cortical area upon in vivo transduction with retro viral vector 
Pax6
Leca2 
CAG-GFP in WT background. (A) GFP immunostaining, (B) GFP immunolabeling merged with the DAPI. Scale 
bars 10µm. 
 
Pax6 is known as a regulator of cell division (Asami et al., 2011), but its involvements in 
the control of the progression of cytokinesis is a novel role which opens as new 
question whether the RED domain controls specific targets sufficient to explain the 
observed phenotype. 
To have new insights on the molecular partners regulated by the RED domain that 
could explain the phenotype in the developing brain, the microarray data derived from 
the developing cortex of the Pax6
Leca2
 (Walcher et al., 2013) were analyzed. From this 
analysis the Holliday junction recognition protein (HJURP) emerged as an interesting 
candidate. 
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4.1.5 Candidate	gene:	HJURP	
The effect of the RED subdomain mutation of Pax6 on the proliferation of progenitors 
observed via live imaging, motivates to analyse genome–wide expression changes 
previously collected (Walcher et al., 2013), in order to identify possible candidates 
suitable to explain the phenotype. 
Microarray analysis was carried out using rostral developing cortices from mutants and 
wild type animals at the developmental stage E14 (Figure 22). The rostral part of the 
cortex was selected based on the knowledge that Pax6 is expressed in a rostral high - 
caudal low gradient (Stoykova et al., 1997; Muzio et al., 2002b). In the microarray 
analysis, among the most upregulated genes (35 genes out of the 94 differentially 
expressed probe sets detected), two seemed particularly promising in explaining the 
prolongation of the cell mitosis: Bub1 (Budding uninhibited by benzimidazoles 1) and 
HJURP (Holliday junction recognition protein). 
The Bub1 gene encodes for a serine/threonine-protein kinase that plays a central role 
in mitosis: it is essential for spindle-assembly checkpoint signaling and for correct 
chromosome alignment (Elowe, 2011). 
Since the upregulation of Bub1 could not be confirmed via quantitative RT-PCR with all 
the sets of primers in independent samples (data not shown), the attention was 
focused on the second candidate: HJURP. 
HJURP is a centromeric protein playing a central role in the incorporation and 
maintenance of histone H3-like variant CENPA at centromeres. HJURP is a chaperone 
for CENPA and is required for the incorporation of newly synthesized CENPA molecules 
into nucleosomes at replicated centromeres. (Stellfox et al., 2013; Muller and 
Almouzni, 2014). The proper organization of the centromere is fundamental for the 
assembly of the centromere-kinetochore structure and the consequent proper 
segregation of the chromatids during mitosis. 
The HJURP gene is upregulated in the Pax6
Leca2 
cortices and such upregulation is 
confirmed via quantitative RT-PCR in independent samples derived from the cortices of 
mutants and wild types (Figure 22 C). 
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Figure 22: HJURP candidate gene 
(A-E) Parts of this figure are adapted from the publication (Walcher et al., 2013). (A) Heat map illustrating the 
expression of the differentially regulated genes in the E14 Pax6
Leca2
 dorsal cortices in comparison with their WT 
littermates. Red/blue indicates higher/lower expression values (Walcher et al., 2013). (B) List of up regulated genes 
in the Pax6
Leca2
, obtained with the genome-wide expression analysis performed by Affymetrix MOE430 2.0 array. 
Differences are determined by a filter consisting of statistical significance (FDR<10%), an average expression level 
exceeding 50 and at least 1.4-fold difference expression (Walcher et al., 2013). Two possible candidate genes to 
explain the phenotype in vivo, 6430706D22Rik also called HJURP and Bub1, are highlighted in red. (C) Histogram 
depicting the linear fold changes of the gene HJURP between the Pax6
Leca2 
and the WT littermates as measured by 
Affimetrix array analysis (black bar) and qRT-PCR (red bar). Student TTEST
 **
P<0.01. (D-E) Micrographs depicting in 
situ hybridization in E14 sections of WT and mutants, showing the mRNA expression for the HJURP gene (Walcher et 
al., 2013). Abbreviations: Ctx: cortex; LGE: lateral ganglionic eminence. 
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4.1.5.1 Expression	of	Hjurp	
The implication of the HJURP protein in the brain was never explored before. To 
further characterize the expression of HJURP in this system, in situ hybridization was 
performed. In the developing cortex (Figure 22 D-E), the mRNA is particularly localized 
in the VZ/SVZ. In the Pax6
Leca2
 mutant (Figure 22 E) the expression of the mRNA for 
HJURP is increased in this cortical area. The localization of HJURP mRNA in the VZ/SVZ 
is in accordance with the function of HJURP that helps the incorporation of newly 
synthesized CENPA at the replicated centromeres during S phase (Stellfox et al., 2013; 
Muller and Almouzni, 2014). In this region in fact, together with the proliferating basal 
progenitors, there are also the radial glia cells (expressing Pax6) in the S phase of their 
cell cycle. Radial glia cells in fact undergo intekinetic nuclear migration which comprise 
that the cell nucleus migrates radially to the basal side of the cells during G1 phase of 
the cell cycle, undergoes to S-phase in basal position and migrates back to the apical 
side for G2-M phase of the cell cycle. 
In the LGE of the Pax6
Leca2 
mutants the increase in the HJURP mRNA appears very 
modest and difficult to confirm. The reason of a less clear result might reside in the 
characteristic heterogeneity of the progenitors present in the LGE. 
4.1.5.2 HJURP	in	vitro	
In order to recapitulate the phenotype observed in vivo in the mutant mice and to 
delineate the contribution of HJURP on it, the protein was overexpressed in vitro on 
P19 cells.  
P19 cells are able to fast proliferate and eventually to differentiate to neurons when 
exposed to specific compounds like retinoic acid (Staines et al., 1994). Therefore, this 
cell line was used to approximate neuronal progenitors in vivo. In this system the 
expression of HJURP was forced via lipofection of plasmid encoding for the protein and 
the GFP (green fluorescent protein) that allows the visualization of the cells expressing 
the protein of interest. 20h after the lipofection, the time necessary to visualize the 
signal from the GFP, the cells were imaged for about 36h until reaching confluency. 
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Figure 23: In vitro live imaging of P19 cells.upon HJURP overexpression 
(A-B) Time series depicting the behavior of cells upon lipofection of the control plasmid (A) and the plasmid 
expressing HJURP (B). Pictures are acquired with an inverted Zeiss Cell-Observer Z1 video microscope. 20 x 
magnification. In A and B the arrow heads indicate examples of cells analyzed. (C) Dot blot depicting the time of 
cytokinesis as previously described for different conditions. Data are represented as mean ± SEM. ***P<0.001, 
Mann-Whitney test. The cells analyzed are coming from n≤3 experiment except the case of the OE of Pax6
Leca2
 
where n=1. (D) Micrographs depicting P19 cells upon HJURP OE immunostained 36h after lipofection. Scale bar 
5µm. 
 
In the cells expressing HJURP was measured the time of cytokinesis. This was 
determined has the time intercurring between the nuclear division and the complete 
scission of the cytoplasm of the two daughter cells; the cells in which the cytokinesis 
was not completed by the end of the movie where excluded from the analysis. 
The overexpression of HJURP (Figure 23 C) leads to a lengthening of the time needed 
to complete the cytoplasmic division of the cells. The cell cytokinesis, upon HJURP 
overexpression, appears impaired and longer than in the wild type condition. The cells 
remain in contact possibly because the DNA in the two nuclei is not completely 
segregate in the daughter cells so that they are blocked from proceeding with the last 
step of cytokinesis (Figure 23 D). 
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P19 cells were imaged also after overexpression of the RED domain mutant form of 
Pax6. In this case a similar effect on cell cycle progression was detected (Figure 23 C). 
This supports the idea of the existence of a tight connection between the RED domain 
of Pax6 and the HJURP protein, in fact following the cells expressing HJURP during their 
division, unravels very similar behaviors than the mutation of the Pax6 RED domain per 
se. 
The current model (Figure 24) starts hypothesizing an inhibitory capacity of the RED 
domain in normal conditions. In the Pax6
Leca2
 the mutation of the RED domain impairs 
this inhibitory function, contributing to the increase of the HJURP mRNA. As a 
consequence, the increment in HJURP leads to a prolongation of the cytokinesis in the 
apical progenitors cells of the developing telencephalon. What remains to be 
elucidated in this regard is the direct implication of Pax6 RED domain on the increase 
of HJURP expression. 
 
 
Figure 24: Working model 
(A-B) Scheme depicting the model suggested by the results obtained from the analysis of the RED domain mutation 
in the developing brain (A) WT, (B) Pax6
Leca2
. 
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4.2 Adult	brain	
The LGE region of the ventral telencephalon gives rise, at postnatal stages, to the cells 
populating the subependymal zone (SEZ), one of the regions where neurogenesis 
persists during adult life (Merkle and Alvarez-Buylla, 2006). 
The progenitors cells present in the LGE of the Pax6
Leca2
 mice are facing defects in cell 
cycle progression, this motivated the assumption that the impairment encountered by 
the progenitors of the LGE might have repercussion on the cells originating from there. 
In addition, giving the fact that the cells populating the SEZ niche express the Pax6 
protein in normal condition (Hsieh, 2012), we used the Pax6
Leca2
 animals as a tool to 
investigate the role of the RED domain of Pax6 in the SEZ region of the adult brain. 
4.2.1 Pax6Leca2	in	adult	brain	
To investigate the repercussion of the RED domain mutation on the adult 
neurogenesis, eight to ten weeks old Pax6
Leca2
 mice were used. Differently from many 
Pax6 mutants which die at birth due to the loss of a protein that has pivotal roles in 
various systems, Pax6
Leca2
 mutants are able to survive after birth and reach adulthood. 
 
 
Figure 25: Gross morphology of Pax6
Leca2
 
(A) Examples of animals of the two genotyping (Walcher et al., 2013). (B) Histogram depicting the difference in body 
weight and brain size between WT (black bar) and Pax6
Leca2
 (red bar). Data are reported as mean ± SEM *P≤0.05; ns: 
non-significant. Unpaired T Test and Upaired TTest with Welch’s correction. (C-D) Gross morphology of the brain in 
the mutants and their WT littermates seen from the top (C) and from the bottom (D) (Walcher et al., 2013). 
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These animals are blind, evident sign of distinction between the homozygotes for the 
missense mutation and their WT littermates (Figure 25A) and they have a smaller body 
mass (Figure 25 B). Looking at the gross morphology of the brain, Pax6
Leca2 
mice have a 
smaller olfactory bulb (OB) even if the brain size is unchanged (Figure 25 B-D). 
At the cellular level, in the adult SEZ-RMS system is evident an accumulation of cells in 
the RMS which starts to be visible as early as E18 in the developing LGE (Figure 26). 
 
 
Figure 26: Cells accumulation in the Pax6
Leca2
 background 
(A-B) Micrographs depicting the ventricular area of E18 WT animals (A) and their mutant littermates (B). 
(C-D) Micrographs depicting the expression of the doublecortin (Dcx) in the SEZ and RMS of 8 weeks old Pax6
Leca2 
mice (D) and their wild type littermate (C). To notice the increase of Dcx+ cells in the SEZ and RMS of the Pax6
Leca2
 
animals. Scale bar 100µm. 
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Two possible hypotheses arouse in order to elucidate the cause of this cell 
accumulation: 
1. The RED domain of Pax6 is relevant for the proper lineage progression in the 
SEZ neurogenic region. Pax6 protein is expressed in the progeny of the stem 
cells lying in the SEZ lateral wall, namely the transit amplifying progenitors 
(TAPs) and the neuroblasts (Hack et al., 2005; Kohwi et al., 2005; Brill et al., 
2008); impairments in their proliferation or differentiation could be the cause 
of the accumulation of cells. 
2. The RED domain of Pax6 has roles in conferring the migratory ability to the cells 
in the SEZ-RMS system. The cells in the RMS, in fact, are characterized by their 
capability to tangentially migrate (Ghashghaei et al., 2007) in order to reach the 
olfactory bulbs. Losing the ability to migrate could cause the aggregation of 
cells in this particular region.  
The attempts directed to the understanding of these possibilities will be discussed in 
the following paragraphs. 
4.2.1.1 Neurogenic	progression	in	the	Pax6Leca2	mutant		
To investigate the involvement of the Pax6 RED domain in the regulation of the cell 
proliferation in the adult SEZ we evaluated the proliferative capacity of TAPs and 
neuroblasts in adult (8 weeks old) Pax6
Leca2
 mutants and their age-matching 
littermates.  
To elucidate if any of the two populations was affected, I analysed the number Dcx-
positive neuroblasts in S-phase of cell cycle based on incorporation of the DNA-base 
analogous BrdU (one hour before sacrificing the animals, 0.5 ml of a 10 mg/ml BrdU 
solution are injected intraperitoneally). This approach followed by the colocalization 
with Dcx allows to discriminate the proliferating neuroblasts (BrdU+ and Dcx+) from 
the TAPs themselves (BrdU only) and locate the origin of the impairment causing 
accumulation of cells in the SEZ-RMS area. 
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Figure 27: Neuroblasts and TAPs proliferation analysis 
(A-B) micrographs representing high magnification pictures of the SEZ-RMS area of the Pax6
Leca2
 and WT animals at 
postnatal stage P56. (C-F) orthogonal picture magnification of cells expressing BrdU and Dcx and BrdU only in WT 
(C-D) and Pax6
Leca2
 (E-F). (G-H) histograms depicting the amount of BrdU+ cells, Dcx+ and of double positive cells for 
Dcx and BrdU in the SEZ and RMS. Fields of view are pictures taken with a 40x magnification 800*800 pixels (2-3 
sections per animals n (number of animal)=3). (I-J) histogram depicting the proportion of double positive cells 
among all the dividing cells and among all the postmitotic neuroblasts in SEZ and RMS.  Data are represented as 
mean ±SEM. Mann-Whiney test for significance ns: non-significant; **P<0.01; ***P<0.001. 
 
In the SEZ the TAPs population (BrdU only cells), similarly to the neuroblasts, is not 
affected by the RED domain mutation. No difference between the mutant animals and 
the WT was detectable in this population in the SEZ area. 
In the RMS the condition is different. Looking at the absolute number of the cells 
positive for the markers is evident that the BrdU only cells are increased (from an 
average of 21.06 ± 3.223 cells in the WT to 35.88 ± 4.219 in the Pax6
Leca2
). 
The hypothesis was that the increase in number in the TAPs population would account 
for the increase of the population of the neuroblasts responsible for the enlargement 
of the RMS in the Pax6
Leca2
. 
To investigate this idea we followed the previous approach (short BrdU pulses) and 
focus the attention on the proliferating neuroblasts which directly generate from the 
TAPs (Doetsch et al., 1999). 
In the SEZ the absolute number of proliferating neuroblasts (Dcx+BrdU+) and of 
postmitotic neuroblasts (Dcx+ only) is unchanged when the two genotypes are 
compared. The difference in neuroblasts number between Pax6
Leca2
 and the WT is 
evident only at the RMS level. 
In the RMS, the number of post mitotic neuroblasts (28.65 ± 4.336 cells in the WT, 
97.19 ± 14.42 the Pax6
Leca2
) and proliferating ones is increased upon RED domain 
mutation (3.000 ± 0.6301 cells in the WT, 6.938 ± 0.5513 in the Pax6
Leca2
). This 
difference nevertheless, disappears when the double positive population (the 
proliferative neuroblasts) is put in relation with total population of the post mitotic 
neuroblasts (Figure 27) and in relation to all the proliferating cells. 
Since no relevant difference could be detected with the short pulse of BrdU paradigm 
explaining the enlargement of the RMS, the hypothesis is that the bulge of cells 
residing in the RMS is originated earlier in development and for poorly understood 
reasons remains in the area being composed by early generated cells and newly 
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supplied cells by the SEZ. In the SEZ of Pax6
Leca2
 animals, in fact, neurogenesis is 
proceeding in a similar manner than in the WT. 
The possibility that in the SEZ of the Pax6
Leca2
 mutants the progression in the cell cycle 
might be delayed and other phases, rather than the S phase, might be affected 
remains still open. 
In the SEZ and RMS system the gene HJURP is in fact expressed in both TAPs and 
neuroblasts. HJURP is the gene that, as shown in the previous chapter, is a possible 
candidate explaining at the molecular level the phenotype seen in the RED domain 
mutant animals having impairments in the cell cycle progression. 
Investigating the data obtained from the transcriptome analysis performed on cells 
isolated from the SEZ niche (Beckervordersandforth et al., 2010), we could reveal the 
presence of HJURP also in the SEZ niche. This gene is primarily present in the stem cells 
(hGFAP/GFP and Prominin+) and then maintained in neuronal lineage having very high 
levels of expression in the progeny of the stem cells (HGFAP/GFP+ only) which, in this 
analysis, is composed by the TAPs and the neuroblasts. 
With the in situ hybridization the HJURP expression was highlighted in SEZ and in the 
RMS (Figure 28). The HJURP expression is high in the RMS of the Pax6
Leca2
 animals 
where the cells show a blockage during the path through the OB. 
The direct connection between HJURP and the enlargement of the RMS is still not 
understood and matter of speculation. The HJURP expression is nevertheless 
representing a bridging point between the adult and the embryonic phenotype. 
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Figure 28: HJURP expression in the adult brain 
(A) Scheme adapted from the original publication (Beckervordersandforth et al., 2010), representing the cell type 
examined by FACS sorting isolation present in adult SEZ niche of the lateral ventricle. (B) Histogram depicting the 
expression levels of HJURP in adult SEZ cells FACS sorted and analyzed via microarray analysis performed with 
Affymetrix MOE430 2.0 arrays (as described in the publication (Beckervordersandforth et al., 2010). hGFAP/GFP+ 
Prominin+: putative stem cells; hGFAP/GFP+only: stem cell progeny comprising of TAPs, neuroblasts and niche 
astrocyte; Diencephalic hGFAP/GFP+: astrocytes outside the niche used as comparison. (C-D) Micrographs depicting 
in situ hybridization in adult brains of Pax6
Leca2
 homozygotes and heterozygotes, which highlight the expression of 
the HJURP mRNA in the SEZ and in particular in the RMS, where the neuroblasts reside. Abbreviations: Ctx: cortex; 
SEZ: subependymal zone. 
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4.2.1.2 Migration	capacity	of	Pax6Leca2	neuroblasts	
Neural precursors originating from the SEZ niche are characterized by their ability to 
migrate tangentially to the OB. Once in the OB they switch to a radial movement in 
order to reach their final location and get integrated into the OB system. 
One further possibility arising to explain the accumulation of cells in the RMS is that 
the neuroblasts upon mutation of the RED domain are incapable to move tangentially 
along the stream. 
To investigate the migratory properties of the neuronal progenitors, the SEZ area was 
isolated and small explants cultivated. In these conditions cells migrate from the 
explant allowing the analysis of the total number of migrating cells, the distance they 
travel and their behavior while migrating. After the migration experiment, explants can 
be fixed and subjected to immunohistochemical analyses to further elucidate the 
effect of the mutation. 
Explants were isolated from the SEZ of P15 animals and placed on the matrigel for 3 
days at 37°C. The distance that the Dcx-positive cells traveled from the explants was 
measured (Figure 29). 
Dcx-positive neuroblasts in the Pax6
Leca2
 mutant migrated the same distance from the 
tissue explants as the Dcx-positive neuroblasts from their age-matched controls (WT: 
mean of the migrating distance 69.90 ± 7.926 µm; Pax6
Leca2
: mean of the migrating 
distance 60.49 ± 4.321µm). From the analysis of the distances of migration of all the 
neuroblasts analyzed was evident that the migratory ability of the neuroblasts in the 
mutant explants was not impaired. In addition, Pax6
Leca2
 mutant neuroblasts formed 
chain structures indistinguishable for the chain structures in their age-matching 
siblings (Figure 29). 
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Figure 29: Neuroblasts migration ability in Pax6
Leca2
 adult brains 
(A) Scheme depicting the paradigm pursued as described in the method part 2.2.1.8. The experiment was repeated 
two times independently with a total of 73 cells Dcx+ in WT animals and 144 cells in Pax6
Leca2
analysed. (B-C) 
Micrographs depicting SEZ explants from P15 mice embedded in matrigel and immunostained after 3days in vitro 
for neuronal markers Dcx, astrocytic marker GFAP and DAPI. Scale bar 50µm. 
(D) Dot blot representing the distance in µm of every cell from the original explant 3days after matrigel embedding. 
Data are showed as mean ± SEM of the distance travelled by the cells in the two genotypes. No-significant 
difference was detectable between the two groups (unpaired TTEST p=0.2568 and Mann-Whitney test p=0.6220). 
 
It is known in fact that neuroblasts migrating through the RMS do so aggregating 
themselves in so called neuronal chains. This phenomenon of cells aggregation is 
spontaneous and autonomous and probably initiated with the contribution of the 
cerebrospinal fluid (CSF) (Ghashghaei et al., 2007). 
Furthermore, the neuroblasts migration via the RMS is a highly directed movement 
and there is no dispersion of any cell into the surrounding tissue because the cells are 
ensheath into an astroglial tube (Jankovski and Sotelo, 1996; Lois et al., 1996) and their 
route is constrained by blood vessel along the RMS (Snapyan et al., 2009).  
To have insight on the presence of these physical substrates that topographically 
define the RMS in the Pax6
Leca2
 mutants, we performed immunohistochemistry. 
In both genotypes the glial tube and the blood vessels delimiting the path of migration 
are present along the RMS (Figure 30) and the Pax6
Leca2
 do not present major 
differences compared to their WT littermates. Therefore, we conclude that the 
accessory structures (glial tubes and blood vessels) necessary to allow the proper 
migration of the cells are all in place. 
These essays suggest that the accumulation of these cells cannot be explained by the 
migratory inability of the neuroblast or absence of any structure that allows the 
migration per se. This supports the idea that the RED domain mutation of Pax6 is not 
impairing their migratory capacity. One possibility still unexploited, which is only 
suggested in this work, is that a further analysis could be conducted in vivo in order to 
prove that, even in the physiological environment, the migratory performances of the 
neuroblasts are not defective. 
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Figure 30: Migrating neuroblasts accessory structures 
(A-B) Micrographs depicting the rostral migratory stream in WT (A) and mutant sections (B). In green is represented 
the glial tube (GFAP positive), in grey the blood vessels highlighted via fluorescent Dextran administered via tail 
injection. The white arrowheads highlight the blood vessels. In the insert zoom of the RMS showing that none of the 
two structures are impaired. Scale bar 50 µm. 
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4.3 Domain	specific	functions	of	Pax6	
Pax6 is defined as master regulator gene. This definition underlines its capability to 
govern the lineage specification process regulating multiple downstream genes either 
directly or via a cascade of gene expression changes  The Pax6 function as fate 
determinant has been previously elucidated in the adult SEZ system as well as in the 
developing cortex, underlying the crucial role of the N-terminal PD domain (Heins et 
al., 2002; Hack et al., 2004; Haubst et al., 2004; Hack et al., 2005; Ninkovic et al., 2013). 
4.3.1 Embryonic	and	Adult	neurospheres	
In order to understand whether the disruption of the binding capacity of the PD 
domain to the DNA is impairing the function of Pax6 in directing neuronal fate 
determination, gain-of-function experiments were performed in neurosphere derived 
culture. 
This culture type allows quantifying the neurogenic capacity of a defined factor. 
Neurosphere derived cultures are, in fact, gliogenic cultures which give rise, 
independently from the region of origin of the cells cultured, to about 80% of glia cells 
(GFAP+ cells) and to 20% of neurons (Dcx+ cells) (Hack et al., 2004). 
When these cells are challenged under certain conditions, e.g. the overexpression of 
neurogenic factors like Pax6, the outcome is reverted with the majority of cells being 
part of the neuronal type (Hack et al., 2004). 
In this analysis neurospheres derived from E14 Cortex and LGE, as well as from adult 
SEZ, were exposed to Pax6 and its two mutant forms (Pax6
Leca2
 and Pax6
Leca4
), via viral 
vector transduction. The different regions and developmental stages were chosen in 
order to validate whether the response of the cells upon exposure to Pax6 depends on 
the context of origin of the cells themselves. 
After the third propagation passage, where the cells were growing in suspension in 
medium supplied with growth factors (EGF and FGF2), the cells were plated and 
transduces with viral vectors expressing Pax6, Pax6
Leca2
 and Pax6
Leca4
. 
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Figure 31: Embryonic ad adult neurosphere 
(A-L) Example of cells derived from neurospheres culture after transfection of control (A-D), Pax6
Leca2
 (E-H) and 
Pax6
Leca4
 viruses (I-L). (M-N) Histogram depicting the number of neurons (Dcx+cells GFP+cells) among the viral 
transduced cells (GFP+cells) in the neurosphere cultures derived from the E14 Cortex and the E14 LGE (M) and the 
adult SEZ (N). (M-N) Histograms are compared with data derived from (Hack et al., 2004), figure 6 of the original 
publication panel E (M), panel D (N). Data are reported as mean± SEM. Unpaired T Test for significance. Non-
significant difference is detected between the cells transfected with a control virus and the Pax6 mutant forms for 
the PAI and the RED domain in E14 derived cells as well as in the adult derived cells. 
 
To measure the neurogenic capacity of the Pax6 PD domain mutants, the number of 
neurons generated from the glial cells was assessed. When the glia cells are exposed to 
the canonical form of Pax6, regardless if they are originating from the cortex, the 
ganglionic eminence (Hack et al., 2004) or the SEZ, they give rise to 60-80% of neurons. 
Differently, exposing the glia cells to the RED domain or PAI domain mutant forms did 
not change the fate of the cells maintaining the number of neurons generated similar 
to the control condition (Figure31). 
These results suggested that, differently from the overexpression of the full Pax6 
protein, the mutated form for the RED domain and the mutated form for the PAI are 
not able to direct the glia cell to the neuronal fate. This is valid for cell originating from 
the developing and the adult brain. 
The activity of only one subdomain of the PD DNA binding domain is not sufficient to 
switch the fate of the glial cells to the neuronal one. 
However, the lack of capability of RED domain mutation to direct glia cells to 
neurogenesis is in contrast with the previous results obtained from primary culture, 
composed by cells already primed to the neurogenic lineage, where the Pax6 RED 
domain mutation was still capable to induce neurogenesis and failed uniquely when 
the PAI domain was impaired (Walcher et al., 2013). 
These results suggest that Pax6 neurogenic capacity is cells specific. The transcription 
factor Pax6 needs the full activity of its PD domain to induce neurogenesis from glia 
cells. In this system both the subdomain PAI and RED are necessary to conduct 
neurogenesis. 
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5 Discussion	
During brain development the control of the proliferation of cells and their fate 
specification is crucial to preserve the equilibrium in every region of the brain, despite 
the high dynamicity of the developing process per se. 
In the telencephalon, the transcription factor Pax6 plays a pivotal role coordinating the 
proliferation of progenitors and their fate specification (Osumi et al., 2008; Georgala et 
al., 2011a). 
This work was aiming to the understanding of the role of the RED domain of Pax6 in 
controlling the cell cycle progression of the progenitors located in the ventral 
telencephalon (LGE) and in the understanding of the relevance of the functionality of 
this domain for the proper progression of the neurogenic process in the postnatal 
subependymal zone that is originating from the LGE. Towards these ends the 
proliferative capacity of the different progenitors in the LGE and the neurogenic 
progression in the adult SEZ were analysed in domain specific mutant mice Pax6
Leca2
. 
The data collected with this work suggest that in the ventral telencephalon the RED 
domain mutation of Pax6 brings to a prolongation of the cytokinesis in the apical 
progenitors cells. The impairments in the cytokinesis prompt to a reduction of cell 
survival. In addition, the RED domain mutation induces the upregulation of the 
chaperone protein HJURP (Holliday junction recognition protein). The upregulation of 
HJURP in vitro recapitulates the phenotype observed in the progenitor cells of the 
Pax6
Leca2 
animals. Differently, in the postnatal neurogenic niche, the impairments in 
binding of the RED domain of Pax6 do not induce failure in the progression through the 
neurogenic lineage. This suggests that the accumulation of neuroblasts, evident in the 
postnatal brain of Pax6
Leca2
 animals, has developmental origin rather than emerging at 
late stages. 
5.1 The	 Pax6	 RED	 subdomain	 is	 responsible	 for	 the	 cell	 cycle	
progression	of	apical	progenitors	
The RED DNA binding domain of the transcription factor Pax6 modulates the 
progression of the cell cytokinesis in the embryonic apical progenitors of the LGE. In 
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the LGE, the exclusive affection of the APs offered the opportunity to resolve the 
importance of the RED domain for the regulation of cell cycle progression without 
additional influence of the cells in the subapical region. In the APs of the LGE, the 
impairment in the RED domain capacity to bind to the DNA leads to a prolongation of 
the cell cytokinesis, unraveling a novel role for this subdomain. 
Pax6 controls the proliferation of the apical progenitor cells of the cerebral cortex. The 
non-functional Pax6 protein leads to alterations in the spindle orientation of the cells 
and consequently of their cleavage plane (Asami et al., 2011). The latter generates 
daughter cells delaminating from the ventricular side which contribute to the increase 
of cells in active mitosis located in subapical positions (Asami et al., 2011). The increase 
in this population of cells is in fact one of the most prominent phenotypes upon 
disruption of Pax6 protein (Warren et al., 1999). 
The PD domain of Pax6 is involved in controlling the proliferative capacity of the RG. 
The exclusive impairment of this domain, in fact, resembles the phenotype of the 
Pax6
Sey
 mutant (Haubst et al., 2004). In particular in the cortical progenitors, the two 
subdomains of the PD domain of Pax6 antagonize in the regulation of proliferative 
genes. Impairing the PAI domain leads to the downregulation of pro-proliferative 
factors (Walcher et al., 2013) suggesting that it might promote proliferation in 
physiological condition. Conversely when the RED subdomain is defective, the 
numbers of PH3 positive progenitors is increased (Walcher et al., 2013), suggesting 
that it might inhibit proliferation in normal condition. 
The increment of PH3 positive cells upon RED domain mutation is a general phenotype 
for the apical progenitor cells expressing Pax6, independently from their location in the 
dorsal or ventral side of the telencephalon. In the LGE, the AP cells population 
encounters an increment of about 30% if compared with the WT situation (Figure 14), 
in the cortex the AP cells almost doubled in comparison to the WT (Walcher et al., 
2013). 
The behavior of the non-apical progenitor cells is different. Upon RED domain 
mutation, in fact, in the cerebral cortex the basal progenitors increase (Walcher et al., 
2013) whereas in the LGE this increment is not occurring either in the subapical 
progenitors or in the basal progenitors. The different behavior of the non-apically 
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dividing cells, in the dorsal and ventral telencephalon, could reside in the different 
response of the progenitors generating them to the RED domain mutation. In the LGE 
SP and BP are originating from the AP that are composed by RG always dividing 
asymmetrically having often, as first progenitor generated, a short neural precursor 
(SNP) also dividing apically (Pilz et al., 2013). In the LGE, SNPs are able to further 
proliferate within the ventricular region before undergoing differentiation (Gal et al., 
2006; Stancik et al., 2010; Tyler and Haydar, 2013) and probably compensate for the 
impairments caused by the mutation. The SNPs in the cortex are rather different. The 
same population directly generates post mitotic neurons (Pilz et al., 2013) leaving to 
the RG task of generating non-apically diving progenitors. The non-apically dividing 
progenitors of dorsal and ventral region might respond differently to the RED domain 
mutation because different is the population that is originating them. 
The increment of PH3 positive mitotic figures is accompanied by a reduction in the cell 
survival (Figure 16), suggesting that the cell cycle of the progenitors was affected. This 
is a common feature between dorsal (Walcher et al., 2013) and ventral regions 
pointing to the necessity of a functional RED domain to properly control the cell cycle 
progression of the progenitors. 
Ex vivo live imaging revealed the indisputable evidence that the last phase of the cell 
division is prolonged upon RED domain mutation and the progenitor cells encounter 
difficulties in concluding their cytokinesis (Figure 19). All the cells dividing during the 
time lapse are affected, but it is difficult to predict which are the identity of the cells 
and their stage of differentiation. The fate of the cells after scission of the two 
daughter cells is still a speculation. In fact, some of them might die as a consequence 
of not proper DNA segregation but most of them might still be able to conclude 
successfully the scission into two daughter’s cells considering that no major defects are 
detected in the region at the moment of the analysis and at later stages. 
This is the first report suggesting the direct implication of Pax6 in the regulation of cell 
cytokinesis. Other transcription factors like the zinc finger transcription factor Sp2 
(specificity protein 2) are reported as regulators of cell cycle progression, in particular 
Sp2 is suggested to be able to regulate centrosomal proteins in the M-phase 
progression (Liang et al., 2013). Knowing the relevance in this context of genes 
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encoding for centrosomal associated proteins and knowing that Pax6 is also relevant in 
the regulation of such genes (Holm et al., 2007) with for example its capability to 
directly target the Spag5 (Asami et al., 2011), I searched for possible targets in the 
microarray of RED domain mutants. Nonetheless, since centrosomal proteins are not 
significantly differentially regulated in the RED domain context, I moved searching for 
targets likable to the found phenotype. 
The evidence that the point mutation in the RED domain (R128C) is causing 
upregulation of the Pax6 mRNA itself (Figure 12), suggests that this is acting as a 
dominant negative mutation This is also further corroborated by two different reporter 
assays in vitro (Walcher et al., 2013; Xie et al., 2013), highlighting that the Pax6
Leca2
 
mutation enhances transcriptional activation and that in physiological condition the 
RED domain has inhibitory functions. 
From these assumptions, the set of upregulated genes in the RED domain mutants in 
comparison with the WT was analyzed. In this group the Holliday junction recognition 
protein (HJURP) was detected. HJURP gene changes directly with the mutation of the 
RED domain. The PAI domain mutation and the non-functional Pax6 do not interfere 
with the expression of the protein HJURP (Walcher et al., 2013). 
HJURP is a CENP-A specific chromatin assembly factor, important for the deposition of 
CENP-A at the centromere (Stellfox et al., 2013). According to the working model, the 
Pax6
Leca2
 mutation leads to the disruption of the inhibitory function of the RED domain 
which leads to the upregulation of this chaperone protein. 
The in vitro upregulation of this protein recapitulates the impairments in cytokinesis 
evident in the RED domain mutant cells. In this work it is suggested that cells with 
mutant Pax6 having HJURP upregulated cannot conclude their cytoplasm scission due 
to the presence of DNA lagging in intercellular bridge. HJURP dysregulation has been in 
fact described as the cause of malfunctioning of the kinetochore which results in 
chromosome instability (Kato et al., 2007; Mishra et al., 2011). 
The direct transcriptional control of this chaperon protein exerted by the RED domain 
of Pax6 is still speculative but nevertheless opens the possibility of a new level of 
regulation of the Pax6 protein acting at the centromere level. 
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5.2 PAI	 and	 RED	 domains	 are	 necessary	 for	 Pax6	 neurogenic	
function	
Neurogenesis is linked to proliferation and in the brain, at different developmental 
stages, depends on Pax6. In the developing cortex, losing this protein causes the 
decrease of cortical neurons (Schmahl et al., 1993; Haubst et al., 2004; Tuoc et al., 
2009); in the adult brain, deletion of Pax6 in the neurogenic zone (SEZ) leads to fate 
conversion of cell towards a glia fate (Ninkovic et al., 2013). In order to accomplish to 
this function at the molecular level Pax6 utilizes the PD domain (Haubst et al., 2004). In 
more details, the improper DNA binding capacity of the PAI subdomain leads to the 
reduction of the neuronal output and concomitantly to the reduction of the 
proliferation capacity of the progenitors. The RED domain mutants, on the contrary, do 
not have defects in neurogenesis (Walcher et al., 2013), indicating that the neurogenic 
fate specification of the progenitors in vivo is achieved prominently by the activity of 
the PAI DNA binding domain. 
The analysis conducted in this work highlighted the importance of both the 
subdomains of the PD to fate convert already committed cells to the neuronal fate. 
Previously was shown that in primary culture derived cells (cells fully committed to the 
neuronal fate from developing cortex) the neurogenic potential of the PD domain of 
Pax6 is abolished only when the PAI subdomain is impaired (Walcher et al., 2013). In 
this condition the activity of the RED subdomain is sufficient to regulate neurogenesis. 
When the cells are in a different context and committed to glia fate, the PAI and RED 
domain simultaneously need to be available to convert the cells to the neuronal fate. 
In embryonic derived neurospheres from dorsal and ventral telencephalon when the 
RED domain of Pax6, or the PAI domain, is impaired the neurogenic capacity of Pax6 is 
lost. When the neurosphere derived cells are transfected with the viral vectors 
expressing both the two mutant forms of Pax6, in the culture are generated a similar 
amount of neurons than in the control conditions (Figure 31). In contrast to the full 
length of Pax6 which is giving rise to about 80% of neurons among the transfect cells in 
these cultures (Hack et al., 2004), in the PAI and RED domain mutant the number of 
neurons is settled around 40% in the embryonic derived cells, and 20% in the adult 
derived cells. The incapability of both the subdomain mutations to fate convert the glia 
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cells is valid for the embryonic derived neurospheres as well for the adult derived 
ones. The comparable reaction of the cells when exposed to neurogenic factors like 
Pax6, independently from the region of origin or the developmental stage of the cells 
cultivated, it is supported by previous results (Hack et al., 2004). What is known is in 
fact that when cells are treated with growth factors (like EGF and FGF), as in the case 
of neurospheres, they are induced to lose their dorsal and ventral identity as well as 
the age difference. Notably, the region specific differences in gene expression among 
cells from cortex or GE are reduced and even neurospheres from adult region contain 
the same expression levels of the same transcription factors with only few exceptions 
(Hack et al., 2004). 
Thus these results suggest that Pax6 neurogenic capacity is cells context specific and 
the transcription factor Pax6 needs the full activity of its PD domain to induce 
neurogenesis and convert fate specification. The lack of capability of RED and PAI 
domains to direct glia cells to neurogenesis, complements the previous results 
obtained from primary culture (Walcher et al., 2013), giving new insides on domain-
specific functions. 
The context specific response of the RED domain in regulating the neurogenic function 
of Pax6 suggests an interesting hypothesis that this mutation impairs the interaction 
with chromatin remodelling factors. Pax6, in fact, has been proposed as a recruiter of 
chromatin remodelling factors to gene loci and Brg1, a chromatin remodelling factor, 
has been shown to directly interact with Pax6 (He et al., 2010; Ninkovic et al., 2013). 
Supposedly, in already committed cells the chromatin is already accessible to be bound 
whereas when the reprogramming machinery has to be ignite by Pax6 is necessary 
that the RED domain is fully active to remove the suppression of neuronal genes and 
be able to convert the fate of the cells. 
The mutation Pax6
Leca2
 is located in the third α-helix of the RED subdomain (Xu et al., 
1999). This causes a change from a positively charged arginine to a neutral cysteine 
which is known to be able to disrupt the helix conformation in different proteins (Lund 
et al., 2008). The conformational changes in the secondary structure of the Pax6 are 
predicted not only to disrupt the interaction with DNA but also might impair protein-
protein interaction. 
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The fact that Pax6 cannot create an interaction with remodelling factors is an 
intriguing hypothesis that opens further fields of investigations. 
5.3 Pax6	 RED	 domain	 affects	 the	 development	 of	 the	 postnatal	
neurogenic	niche	
In the adult brain, at physiological conditions, the stem cells residing in the 
subependymal zone (SEZ), via multiple step of fate restriction, progress through the 
neurogenic process. Neuroblasts, young neurons generated in this area, move along 
the rostral migratory stream to reach the olfactory bulbs. 
In the Pax6
Leca2
 background, in the area where the neuroblasts enter in the rostral 
migratory stream, there is an accumulation of cells. These cells express the neurogenic 
marker doublecortine (Dcx), suggesting that they derive from neurogenic process that 
might be impaired at different levels. Nevertheless, from the analysis conducted in this 
work, there is no evidence supporting that the cells accumulate at postnatal stages. In 
the Pax6
Leca2
 in fact, neither the neuroblast production nor their intrinsic capability to 
migrate are impaired. 
These suggestions all point to the fact that the RED domain functionality is not 
determinant for the progression of the neurogenic process in the adult SEZ, or could 
be replaced by the PAI subdomain. 
The hypothesis that is supported is that the accumulation of cells located in the RMS 
has a different developmental origin. The SEZ-OB system is in fact originating from the 
LGE (Merkle and Alvarez-Buylla, 2006). 
In the LGE region of the mutant animals, has described above, the apical progenitors 
are facing a prolonged cytokinesis and the protein HJURP is taking part on this process. 
In the cells present in the RMS of Pax6
Leca2
 mice HJURP mRNA is present and I cannot 
exclude a role of this protein in the regulation of the cell cycle process, at least in a 
subpopulation of cells residing in the SEZ-RMS region. 
In addition, an evident phenotype of the RED domain mutant animals is the presence 
of a reduced OB and this can also be due to improper cell cycle progression in the LGE. 
The OB develops very early during embryogenesis from a predetermined region of the 
rostral telencephalon (Lopez-Mascaraque et al., 1996). The OB system is composed by 
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projection neurons and interneurons. The second group is composed by granule cells 
and periglomerular cells. These cells are largely generated during early postnatal life 
and their production is maintained lifelong (Rosselli-Austin and Altman, 1979; Ming 
and Song, 2005). 
However, was found that the LGE is the primary source of early generated OB 
interneurons (Tucker et al., 2006). These cells, originating from the LGE, migrate via a 
primordium of RMS into the prospective OB between E12.5 and E14 (Tucker et al., 
2006). Their capability to migrate is acquired in the LGE environment between E9.5 
and E11 (Tucker et al., 2006). Supposedly in the LGE of the Pax6
Leca2
 animals, the 
impairment in cell cycle progression might lead not only to depauperate the numbers 
of cells reaching the OB but also to decrease their migratory fidelity. 
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then it was definitely worth doing it. 
Grazie a tutti. 
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